This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are
presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.
"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.
Num | microRNA | Gene | miRNA log2FC | miRNA pvalue | Gene log2FC | Gene pvalue | Interaction | Correlation beta | Correlation P-value | PMID | Reported in cancer studies |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | hsa-miR-186-5p | APC | 0.45 | 0.18545 | -0.08 | 0.84234 | miRNAWalker2 validate | -0.19 | 0.00487 | NA | |
2 | hsa-miR-30a-3p | APC | -1.22 | 0.16757 | -0.08 | 0.84234 | MirTarget; miRNATAP | -0.11 | 1.0E-5 | NA | |
3 | hsa-miR-320b | APC | 0.2 | 0.72722 | -0.08 | 0.84234 | miRanda | -0.12 | 0.00135 | NA | |
4 | hsa-miR-374b-5p | APC | -0.11 | 0.76489 | -0.08 | 0.84234 | mirMAP | -0.19 | 0.00128 | NA | |
5 | hsa-miR-590-3p | APC | 2.35 | 0 | -0.08 | 0.84234 | PITA; miRanda; mirMAP; miRNATAP | -0.17 | 0.0001 | NA | |
6 | hsa-miR-7-1-3p | APC | 1.43 | 0.00471 | -0.08 | 0.84234 | MirTarget | -0.15 | 0.00061 | NA | |
7 | hsa-miR-125a-5p | APC2 | -1.32 | 0.00714 | 3.13 | 0.00737 | mirMAP | -0.85 | 0 | NA | |
8 | hsa-miR-194-3p | APC2 | 1.92 | 0.10538 | 3.13 | 0.00737 | mirMAP | -0.16 | 0.00507 | NA | |
9 | hsa-miR-28-5p | APC2 | -0.82 | 0.02212 | 3.13 | 0.00737 | mirMAP | -0.67 | 0.00043 | NA | |
10 | hsa-let-7a-3p | AXIN2 | 0.83 | 0.04681 | -3.82 | 0.00033 | miRNATAP | -0.49 | 0.00085 | NA | |
11 | hsa-let-7b-3p | AXIN2 | 0.59 | 0.20051 | -3.82 | 0.00033 | miRNATAP | -0.5 | 0.00019 | NA | |
12 | hsa-let-7f-2-3p | AXIN2 | 1.03 | 0.07873 | -3.82 | 0.00033 | MirTarget | -0.36 | 0.00084 | NA | |
13 | hsa-miR-15a-5p | AXIN2 | 2.05 | 0 | -3.82 | 0.00033 | MirTarget; miRNATAP | -0.55 | 8.0E-5 | 26252081 | The combination of miR-15a and AXIN2 significantly improved the diagnostic accuracy |
14 | hsa-miR-15b-5p | AXIN2 | 3.32 | 0 | -3.82 | 0.00033 | miRTarBase; MirTarget; miRNATAP | -0.47 | 0.00022 | NA | |
15 | hsa-miR-16-2-3p | AXIN2 | 3.8 | 0 | -3.82 | 0.00033 | mirMAP | -0.68 | 0 | NA | |
16 | hsa-miR-16-5p | AXIN2 | 2.94 | 0 | -3.82 | 0.00033 | miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP | -0.7 | 0 | NA | |
17 | hsa-miR-205-5p | AXIN2 | 8.08 | 0 | -3.82 | 0.00033 | miRNATAP | -0.3 | 0 | NA | |
18 | hsa-miR-221-3p | AXIN2 | 0.94 | 0.17475 | -3.82 | 0.00033 | miRNATAP | -0.52 | 0 | NA | |
19 | hsa-miR-222-3p | AXIN2 | 1.55 | 0.0223 | -3.82 | 0.00033 | miRNATAP | -0.53 | 0 | NA | |
20 | hsa-miR-3614-5p | AXIN2 | 4.5 | 0 | -3.82 | 0.00033 | MirTarget; miRNATAP | -0.26 | 0.00012 | NA | |
21 | hsa-miR-590-3p | AXIN2 | 2.35 | 0 | -3.82 | 0.00033 | MirTarget; PITA; miRanda; miRNATAP | -0.5 | 3.0E-5 | NA | |
22 | hsa-miR-944 | AXIN2 | 7.21 | 0.00082 | -3.82 | 0.00033 | MirTarget; PITA; miRNATAP | -0.28 | 0 | NA | |
23 | hsa-let-7e-5p | BTRC | -0.11 | 0.81474 | -0.39 | 0.22952 | miRNAWalker2 validate | -0.16 | 4.0E-5 | NA | |
24 | hsa-miR-125a-3p | BTRC | -0.07 | 0.92074 | -0.39 | 0.22952 | miRanda | -0.11 | 0 | NA | |
25 | hsa-miR-15b-5p | BTRC | 3.32 | 0 | -0.39 | 0.22952 | MirTarget; miRNATAP | -0.14 | 0.00015 | NA | |
26 | hsa-miR-16-5p | BTRC | 2.94 | 0 | -0.39 | 0.22952 | miRNAWalker2 validate; MirTarget; miRNATAP | -0.13 | 0.00072 | NA | |
27 | hsa-miR-28-5p | BTRC | -0.82 | 0.02212 | -0.39 | 0.22952 | miRanda | -0.24 | 0 | NA | |
28 | hsa-miR-339-5p | BTRC | 1.23 | 0.03075 | -0.39 | 0.22952 | MirTarget; miRanda | -0.11 | 0.00101 | NA | |
29 | hsa-miR-3913-5p | BTRC | 0.15 | 0.73484 | -0.39 | 0.22952 | mirMAP | -0.16 | 0.00018 | NA | |
30 | hsa-miR-505-3p | BTRC | 0.59 | 0.22694 | -0.39 | 0.22952 | MirTarget | -0.1 | 0.00592 | NA | |
31 | hsa-miR-10a-5p | CAMK2A | -0.48 | 0.59461 | -4.61 | 0.0001 | mirMAP | -0.42 | 0 | NA | |
32 | hsa-miR-130b-5p | CAMK2A | 3.74 | 0 | -4.61 | 0.0001 | mirMAP | -0.55 | 0 | NA | |
33 | hsa-miR-148b-5p | CAMK2A | 2.81 | 0 | -4.61 | 0.0001 | mirMAP | -0.36 | 0.00552 | NA | |
34 | hsa-miR-15b-3p | CAMK2A | 3.58 | 0 | -4.61 | 0.0001 | mirMAP | -0.37 | 0.0021 | NA | |
35 | hsa-miR-19b-1-5p | CAMK2A | 1.51 | 0.00147 | -4.61 | 0.0001 | mirMAP | -0.38 | 0.00728 | NA | |
36 | hsa-miR-25-3p | CAMK2A | 1.13 | 0.00311 | -4.61 | 0.0001 | MirTarget | -0.82 | 0 | NA | |
37 | hsa-miR-30a-5p | CAMK2A | -0.77 | 0.32049 | -4.61 | 0.0001 | mirMAP | -0.26 | 0.00345 | NA | |
38 | hsa-miR-30d-5p | CAMK2A | 0.3 | 0.38019 | -4.61 | 0.0001 | mirMAP | -0.78 | 0.0001 | NA | |
39 | hsa-miR-30e-5p | CAMK2A | 0.78 | 0.03467 | -4.61 | 0.0001 | mirMAP | -0.49 | 0.00851 | NA | |
40 | hsa-miR-32-5p | CAMK2A | 2.93 | 0 | -4.61 | 0.0001 | MirTarget | -0.38 | 0.00666 | NA | |
41 | hsa-miR-338-3p | CAMK2A | 0.45 | 0.55849 | -4.61 | 0.0001 | miRNATAP | -0.27 | 0.00277 | NA | |
42 | hsa-miR-361-3p | CAMK2A | 0.81 | 0.04185 | -4.61 | 0.0001 | mirMAP | -0.68 | 8.0E-5 | NA | |
43 | hsa-miR-363-3p | CAMK2A | 4.27 | 1.0E-5 | -4.61 | 0.0001 | MirTarget | -0.42 | 0 | NA | |
44 | hsa-miR-3913-5p | CAMK2A | 0.15 | 0.73484 | -4.61 | 0.0001 | mirMAP | -0.46 | 0.004 | NA | |
45 | hsa-miR-429 | CAMK2A | 6.4 | 0 | -4.61 | 0.0001 | miRNATAP | -0.6 | 0 | NA | |
46 | hsa-miR-616-5p | CAMK2A | 2.48 | 0.00318 | -4.61 | 0.0001 | mirMAP | -0.44 | 1.0E-5 | NA | |
47 | hsa-miR-625-5p | CAMK2A | 2.03 | 0.00094 | -4.61 | 0.0001 | mirMAP | -0.46 | 3.0E-5 | NA | |
48 | hsa-miR-7-1-3p | CAMK2A | 1.43 | 0.00471 | -4.61 | 0.0001 | MirTarget | -0.37 | 0.00584 | NA | |
49 | hsa-miR-92a-3p | CAMK2A | 1.88 | 1.0E-5 | -4.61 | 0.0001 | MirTarget | -0.41 | 0.00918 | NA | |
50 | hsa-miR-92b-3p | CAMK2A | 1.69 | 0.01035 | -4.61 | 0.0001 | MirTarget | -0.46 | 1.0E-5 | NA | |
51 | hsa-miR-29a-3p | CAMK2B | -0.64 | 0.25192 | 1.67 | 0.24793 | mirMAP | -0.46 | 0.00193 | NA | |
52 | hsa-miR-29b-3p | CAMK2B | 0.67 | 0.23406 | 1.67 | 0.24793 | mirMAP | -0.45 | 0.00212 | NA | |
53 | hsa-miR-139-5p | CAMK2D | -2.09 | 0.00038 | -0.44 | 0.41573 | PITA; miRanda | -0.17 | 0.00085 | NA | |
54 | hsa-miR-197-3p | CAMK2D | 1.24 | 0.00733 | -0.44 | 0.41573 | miRNATAP | -0.2 | 0.00262 | NA | |
55 | hsa-miR-217 | CAMK2D | -0.38 | 0.71741 | -0.44 | 0.41573 | miRanda | -0.1 | 0.00041 | NA | |
56 | hsa-miR-27a-3p | CAMK2D | 1.76 | 0.00022 | -0.44 | 0.41573 | miRNATAP | -0.18 | 0.00395 | NA | |
57 | hsa-miR-30a-5p | CAMK2D | -0.77 | 0.32049 | -0.44 | 0.41573 | miRNATAP | -0.11 | 0.00545 | NA | |
58 | hsa-miR-30b-5p | CAMK2D | 0.02 | 0.95322 | -0.44 | 0.41573 | miRNATAP | -0.21 | 0.00569 | NA | |
59 | hsa-miR-30c-5p | CAMK2D | 0.39 | 0.34861 | -0.44 | 0.41573 | miRNATAP | -0.21 | 0.0044 | NA | |
60 | hsa-miR-32-3p | CAMK2D | 2.2 | 0.03928 | -0.44 | 0.41573 | mirMAP | -0.2 | 4.0E-5 | NA | |
61 | hsa-miR-320b | CAMK2D | 0.2 | 0.72722 | -0.44 | 0.41573 | miRanda | -0.14 | 0.00911 | NA | |
62 | hsa-miR-484 | CAMK2D | 1.79 | 0.00022 | -0.44 | 0.41573 | miRNAWalker2 validate | -0.19 | 0.00289 | NA | |
63 | hsa-miR-582-5p | CAMK2D | 0.69 | 0.44776 | -0.44 | 0.41573 | mirMAP | -0.22 | 0 | NA | |
64 | hsa-miR-107 | CAMK2G | 1.49 | 0.00013 | -0.7 | 0.02836 | miRNATAP | -0.12 | 0.00895 | NA | |
65 | hsa-miR-181a-5p | CAMK2G | 1.26 | 0.00749 | -0.7 | 0.02836 | miRNATAP | -0.18 | 0 | NA | |
66 | hsa-miR-181b-5p | CAMK2G | 1.11 | 0.02734 | -0.7 | 0.02836 | miRNATAP | -0.18 | 0 | NA | |
67 | hsa-miR-181c-5p | CAMK2G | -0.3 | 0.53753 | -0.7 | 0.02836 | miRNATAP | -0.13 | 0.00026 | NA | |
68 | hsa-miR-484 | CAMK2G | 1.79 | 0.00022 | -0.7 | 0.02836 | mirMAP | -0.11 | 0.00362 | NA | |
69 | hsa-miR-628-5p | CAMK2G | 1.05 | 0.02524 | -0.7 | 0.02836 | MirTarget; PITA; miRNATAP | -0.17 | 1.0E-5 | NA | |
70 | hsa-let-7a-5p | CCND1 | 0.15 | 0.64531 | 0.15 | 0.87753 | TargetScan; miRNATAP | -0.54 | 0.00245 | NA | |
71 | hsa-miR-106a-5p | CCND1 | 3.99 | 0 | 0.15 | 0.87753 | MirTarget; miRNATAP | -0.43 | 0 | NA | |
72 | hsa-miR-15a-5p | CCND1 | 2.05 | 0 | 0.15 | 0.87753 | miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP | -0.35 | 0.00776 | 22922827 | CCND1 has been found to be a target of miR-15a and miR-16-1 through analysis of complementary sequences between microRNAs and CCND1 mRNA; Moreover the transcription of CCND1 is suppressed by miR-15a and miR-16-1 via direct binding to the CCND1 3'-untranslated region 3'-UTR |
73 | hsa-miR-15b-5p | CCND1 | 3.32 | 0 | 0.15 | 0.87753 | miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP | -0.42 | 0.00029 | NA | |
74 | hsa-miR-20b-5p | CCND1 | 4.57 | 5.0E-5 | 0.15 | 0.87753 | MirTarget; miRNATAP | -0.31 | 0 | NA | |
75 | hsa-miR-34a-5p | CCND1 | 0.83 | 0.04775 | 0.15 | 0.87753 | miRNAWalker2 validate; miRTarBase; miRNATAP | -0.42 | 0.00174 | 25792709; 21399894 | This inhibition of proliferation was associated with a decrease in cyclin D1 levels orchestrated principally by HNF-4α a target of miR-34a considered to act as a tumour suppressor in the liver;Quantitative PCR and western analysis confirmed decreased expression of two genes BCL-2 and CCND1 in docetaxel-resistant cells which are both targeted by miR-34a |
76 | hsa-miR-497-5p | CCND1 | -1.44 | 0.02251 | 0.15 | 0.87753 | MirTarget; miRNATAP | -0.25 | 0.00498 | 21350001 | Raf-1 and Ccnd1 were identified as novel direct targets of miR-195 and miR-497 miR-195/497 expression levels in clinical specimens were found to be correlated inversely with malignancy of breast cancer |
77 | hsa-miR-106a-5p | CCND2 | 3.99 | 0 | -2.81 | 0.0014 | miRNATAP | -0.44 | 0 | NA | |
78 | hsa-miR-106b-5p | CCND2 | 2.81 | 0 | -2.81 | 0.0014 | miRNAWalker2 validate; miRTarBase; miRNATAP | -0.31 | 0.00374 | NA | |
79 | hsa-miR-10a-3p | CCND2 | 0.97 | 0.31667 | -2.81 | 0.0014 | mirMAP | -0.2 | 0.00011 | NA | |
80 | hsa-miR-130b-5p | CCND2 | 3.74 | 0 | -2.81 | 0.0014 | mirMAP | -0.46 | 0 | NA | |
81 | hsa-miR-141-3p | CCND2 | 7.3 | 0 | -2.81 | 0.0014 | MirTarget; TargetScan | -0.24 | 0.00021 | NA | |
82 | hsa-miR-15b-5p | CCND2 | 3.32 | 0 | -2.81 | 0.0014 | miRNATAP | -0.53 | 0 | NA | |
83 | hsa-miR-16-2-3p | CCND2 | 3.8 | 0 | -2.81 | 0.0014 | mirMAP | -0.29 | 0.00207 | NA | |
84 | hsa-miR-182-5p | CCND2 | 5.87 | 0 | -2.81 | 0.0014 | miRNAWalker2 validate; miRTarBase; miRNATAP | -0.28 | 2.0E-5 | NA | |
85 | hsa-miR-183-5p | CCND2 | 6.62 | 0 | -2.81 | 0.0014 | miRNATAP | -0.29 | 0 | NA | |
86 | hsa-miR-191-5p | CCND2 | 1.59 | 0.00074 | -2.81 | 0.0014 | MirTarget | -0.32 | 0.00314 | NA | |
87 | hsa-miR-200a-3p | CCND2 | 6.34 | 0 | -2.81 | 0.0014 | MirTarget | -0.41 | 0 | NA | |
88 | hsa-miR-20b-5p | CCND2 | 4.57 | 5.0E-5 | -2.81 | 0.0014 | miRNATAP | -0.3 | 0 | NA | |
89 | hsa-miR-224-3p | CCND2 | 2.85 | 0.00018 | -2.81 | 0.0014 | mirMAP | -0.22 | 0.00101 | NA | |
90 | hsa-miR-28-5p | CCND2 | -0.82 | 0.02212 | -2.81 | 0.0014 | miRanda | -0.43 | 0.00273 | NA | |
91 | hsa-miR-3065-3p | CCND2 | 1.89 | 0.03082 | -2.81 | 0.0014 | MirTarget; miRNATAP | -0.21 | 0.00027 | NA | |
92 | hsa-miR-3065-5p | CCND2 | 2.14 | 0.06094 | -2.81 | 0.0014 | mirMAP | -0.2 | 0.00026 | NA | |
93 | hsa-miR-30d-3p | CCND2 | -0.07 | 0.85742 | -2.81 | 0.0014 | mirMAP | -0.55 | 1.0E-5 | NA | |
94 | hsa-miR-324-3p | CCND2 | 1.51 | 0.00384 | -2.81 | 0.0014 | miRNAWalker2 validate | -0.44 | 0 | NA | |
95 | hsa-miR-33a-3p | CCND2 | 2.06 | 0.00156 | -2.81 | 0.0014 | MirTarget | -0.27 | 0.00041 | NA | |
96 | hsa-miR-378a-3p | CCND2 | 1.47 | 0.04667 | -2.81 | 0.0014 | miRNAWalker2 validate | -0.19 | 0.00601 | NA | |
97 | hsa-miR-429 | CCND2 | 6.4 | 0 | -2.81 | 0.0014 | miRNATAP | -0.46 | 0 | NA | |
98 | hsa-miR-497-5p | CCND2 | -1.44 | 0.02251 | -2.81 | 0.0014 | MirTarget; miRNATAP | -0.27 | 0.00058 | NA | |
99 | hsa-miR-550a-5p | CCND2 | 1.22 | 0.06138 | -2.81 | 0.0014 | MirTarget | -0.22 | 0.00363 | NA | |
100 | hsa-miR-660-5p | CCND2 | -0.07 | 0.88525 | -2.81 | 0.0014 | mirMAP | -0.29 | 0.00793 | NA | |
101 | hsa-miR-9-3p | CCND2 | 1.69 | 0.12517 | -2.81 | 0.0014 | MirTarget; mirMAP; miRNATAP | -0.14 | 0.00185 | NA | |
102 | hsa-miR-93-5p | CCND2 | 2.66 | 0 | -2.81 | 0.0014 | miRNATAP | -0.48 | 0 | NA | |
103 | hsa-miR-96-5p | CCND2 | 5.63 | 0 | -2.81 | 0.0014 | TargetScan; miRNATAP | -0.24 | 0.0003 | NA | |
104 | hsa-miR-27b-3p | CCND3 | -0.09 | 0.85847 | -0.54 | 0.12437 | miRNAWalker2 validate | -0.14 | 0.00019 | NA | |
105 | hsa-miR-429 | CCND3 | 6.4 | 0 | -0.54 | 0.12437 | miRNATAP | -0.11 | 1.0E-5 | NA | |
106 | hsa-miR-96-5p | CCND3 | 5.63 | 0 | -0.54 | 0.12437 | TargetScan | -0.12 | 1.0E-5 | NA | |
107 | hsa-miR-582-5p | CHP2 | 0.69 | 0.44776 | 1.48 | 0.50956 | miRNATAP | -0.42 | 0.00313 | NA | |
108 | hsa-miR-21-3p | CREBBP | 3.5 | 0 | -0.4 | 0.18067 | MirTarget | -0.14 | 0 | NA | |
109 | hsa-miR-590-3p | CREBBP | 2.35 | 0 | -0.4 | 0.18067 | PITA; miRanda; mirMAP; miRNATAP | -0.1 | 0.00219 | NA | |
110 | hsa-miR-186-5p | CSNK1A1 | 0.45 | 0.18545 | 0.25 | 0.39557 | miRNAWalker2 validate; miRNATAP | -0.19 | 8.0E-5 | NA | |
111 | hsa-miR-30a-5p | CSNK1A1 | -0.77 | 0.32049 | 0.25 | 0.39557 | MirTarget; miRNATAP | -0.14 | 0 | NA | |
112 | hsa-miR-7-1-3p | CSNK1A1 | 1.43 | 0.00471 | 0.25 | 0.39557 | mirMAP | -0.12 | 0.00016 | NA | |
113 | hsa-miR-125a-5p | CSNK2A1 | -1.32 | 0.00714 | 0.48 | 0.09134 | MirTarget; PITA; miRanda | -0.11 | 0.00094 | NA | |
114 | hsa-miR-342-3p | CTBP2 | 1.31 | 0.02072 | -0.53 | 0.12195 | MirTarget; PITA; miRanda; miRNATAP | -0.13 | 0.00023 | NA | |
115 | hsa-miR-150-5p | CTNNB1 | 1.77 | 0.05938 | -0.6 | 0.15222 | MirTarget | -0.12 | 0 | NA | |
116 | hsa-miR-155-5p | CTNNB1 | 2.81 | 7.0E-5 | -0.6 | 0.15222 | miRNAWalker2 validate | -0.17 | 0 | NA | |
117 | hsa-miR-221-3p | CTNNB1 | 0.94 | 0.17475 | -0.6 | 0.15222 | miRNAWalker2 validate | -0.15 | 1.0E-5 | NA | |
118 | hsa-miR-330-3p | CTNNB1 | 2.49 | 0.00013 | -0.6 | 0.15222 | MirTarget; PITA; miRNATAP | -0.11 | 0.00159 | NA | |
119 | hsa-miR-590-3p | CTNNB1 | 2.35 | 0 | -0.6 | 0.15222 | miRanda | -0.16 | 0.00059 | NA | |
120 | hsa-miR-10a-5p | CTNNBIP1 | -0.48 | 0.59461 | 1.03 | 0.01773 | miRNATAP | -0.13 | 0 | NA | |
121 | hsa-miR-125a-3p | CTNNBIP1 | -0.07 | 0.92074 | 1.03 | 0.01773 | miRanda | -0.17 | 0 | NA | |
122 | hsa-miR-125a-5p | CTNNBIP1 | -1.32 | 0.00714 | 1.03 | 0.01773 | mirMAP | -0.19 | 0.00017 | NA | |
123 | hsa-miR-192-5p | CTNNBIP1 | 1.78 | 0.11349 | 1.03 | 0.01773 | miRNAWalker2 validate; MirTarget; miRNATAP | -0.13 | 0 | NA | |
124 | hsa-miR-215-5p | CTNNBIP1 | 3.67 | 0.00295 | 1.03 | 0.01773 | miRNAWalker2 validate; MirTarget | -0.1 | 0 | NA | |
125 | hsa-miR-335-5p | CTNNBIP1 | 0.17 | 0.8039 | 1.03 | 0.01773 | miRNAWalker2 validate; mirMAP | -0.16 | 1.0E-5 | NA | |
126 | hsa-miR-505-5p | CTNNBIP1 | -0.55 | 0.33141 | 1.03 | 0.01773 | MirTarget | -0.13 | 0.00352 | NA | |
127 | hsa-miR-625-5p | CTNNBIP1 | 2.03 | 0.00094 | 1.03 | 0.01773 | mirMAP | -0.12 | 0.00286 | NA | |
128 | hsa-miR-92b-3p | CTNNBIP1 | 1.69 | 0.01035 | 1.03 | 0.01773 | miRNATAP | -0.2 | 0 | NA | |
129 | hsa-let-7g-3p | DAAM1 | 2.1 | 5.0E-5 | 0.28 | 0.67526 | MirTarget | -0.3 | 3.0E-5 | NA | |
130 | hsa-miR-125a-5p | DAAM1 | -1.32 | 0.00714 | 0.28 | 0.67526 | MirTarget | -0.28 | 0.00028 | NA | |
131 | hsa-miR-181c-5p | DAAM1 | -0.3 | 0.53753 | 0.28 | 0.67526 | mirMAP | -0.26 | 0.00068 | NA | |
132 | hsa-miR-186-5p | DAAM1 | 0.45 | 0.18545 | 0.28 | 0.67526 | MirTarget; mirMAP | -0.54 | 0 | NA | |
133 | hsa-miR-194-5p | DAAM1 | 0.69 | 0.52314 | 0.28 | 0.67526 | miRNATAP | -0.17 | 0 | NA | |
134 | hsa-miR-29b-3p | DAAM1 | 0.67 | 0.23406 | 0.28 | 0.67526 | MirTarget; miRNATAP | -0.19 | 0.00398 | NA | |
135 | hsa-miR-29c-3p | DAAM1 | -0.41 | 0.52934 | 0.28 | 0.67526 | MirTarget; miRNATAP | -0.16 | 0.00523 | NA | |
136 | hsa-miR-32-5p | DAAM1 | 2.93 | 0 | 0.28 | 0.67526 | miRNATAP | -0.22 | 0.00486 | NA | |
137 | hsa-miR-335-5p | DAAM1 | 0.17 | 0.8039 | 0.28 | 0.67526 | miRNAWalker2 validate; MirTarget; miRNATAP | -0.19 | 0.0006 | NA | |
138 | hsa-miR-34a-5p | DAAM1 | 0.83 | 0.04775 | 0.28 | 0.67526 | MirTarget; miRNATAP | -0.33 | 0.00028 | NA | |
139 | hsa-miR-362-3p | DAAM1 | 0.68 | 0.22615 | 0.28 | 0.67526 | MirTarget; miRanda; miRNATAP | -0.21 | 0.00131 | NA | |
140 | hsa-miR-454-3p | DAAM1 | 1.4 | 0.00366 | 0.28 | 0.67526 | MirTarget; miRNATAP | -0.24 | 0.00186 | NA | |
141 | hsa-miR-590-3p | DAAM1 | 2.35 | 0 | 0.28 | 0.67526 | MirTarget; miRanda; mirMAP | -0.24 | 0.00087 | NA | |
142 | hsa-miR-92b-3p | DAAM1 | 1.69 | 0.01035 | 0.28 | 0.67526 | miRNATAP | -0.18 | 0.00158 | NA | |
143 | hsa-miR-141-5p | DAAM2 | 7.14 | 0 | -4.26 | 1.0E-5 | mirMAP | -0.57 | 0 | NA | |
144 | hsa-miR-182-5p | DAAM2 | 5.87 | 0 | -4.26 | 1.0E-5 | mirMAP | -0.21 | 0.00366 | NA | |
145 | hsa-miR-18a-5p | DAAM2 | 3.91 | 0 | -4.26 | 1.0E-5 | miRNAWalker2 validate | -0.31 | 0.00023 | NA | |
146 | hsa-miR-193a-3p | DAAM2 | 0.65 | 0.20713 | -4.26 | 1.0E-5 | miRanda | -0.49 | 0 | NA | |
147 | hsa-miR-1976 | DAAM2 | 3.27 | 0 | -4.26 | 1.0E-5 | mirMAP | -0.55 | 0 | NA | |
148 | hsa-miR-205-5p | DAAM2 | 8.08 | 0 | -4.26 | 1.0E-5 | mirMAP | -0.19 | 0 | NA | |
149 | hsa-miR-339-5p | DAAM2 | 1.23 | 0.03075 | -4.26 | 1.0E-5 | miRanda | -0.4 | 2.0E-5 | NA | |
150 | hsa-miR-361-3p | DAAM2 | 0.81 | 0.04185 | -4.26 | 1.0E-5 | mirMAP | -0.67 | 0 | NA |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | WNT SIGNALING PATHWAY | 64 | 351 | 1.612e-89 | 7.499e-86 |
2 | CANONICAL WNT SIGNALING PATHWAY | 37 | 95 | 3.752e-63 | 8.729e-60 |
3 | NON CANONICAL WNT SIGNALING PATHWAY | 33 | 140 | 1.23e-47 | 1.907e-44 |
4 | REGULATION OF WNT SIGNALING PATHWAY | 39 | 310 | 3.435e-45 | 3.996e-42 |
5 | REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 30 | 236 | 1.547e-34 | 1.439e-31 |
6 | NEGATIVE REGULATION OF WNT SIGNALING PATHWAY | 28 | 197 | 1.293e-33 | 1.002e-30 |
7 | REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS | 45 | 1021 | 3.893e-32 | 2.588e-29 |
8 | REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 53 | 1672 | 1.541e-31 | 8.962e-29 |
9 | POSITIVE REGULATION OF RESPONSE TO STIMULUS | 54 | 1929 | 1.562e-29 | 8.076e-27 |
10 | REGULATION OF ORGAN MORPHOGENESIS | 27 | 242 | 1.88e-29 | 8.748e-27 |
11 | MORPHOGENESIS OF AN EPITHELIUM | 31 | 400 | 6.239e-29 | 2.639e-26 |
12 | POSITIVE REGULATION OF GENE EXPRESSION | 51 | 1733 | 1.38e-28 | 5.351e-26 |
13 | TISSUE MORPHOGENESIS | 33 | 533 | 1.108e-27 | 3.965e-25 |
14 | NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 23 | 162 | 1.373e-27 | 4.563e-25 |
15 | POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS | 47 | 1492 | 2.922e-27 | 9.063e-25 |
16 | EPITHELIUM DEVELOPMENT | 39 | 945 | 2.162e-26 | 6.287e-24 |
17 | ORGAN MORPHOGENESIS | 37 | 841 | 6.524e-26 | 1.786e-23 |
18 | POSITIVE REGULATION OF CELL COMMUNICATION | 46 | 1532 | 1.043e-25 | 2.696e-23 |
19 | WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY | 15 | 39 | 1.678e-25 | 4.109e-23 |
20 | TISSUE DEVELOPMENT | 45 | 1518 | 7.697e-25 | 1.791e-22 |
21 | REGULATION OF PROTEIN MODIFICATION PROCESS | 47 | 1710 | 1.081e-24 | 2.396e-22 |
22 | TUBE MORPHOGENESIS | 26 | 323 | 1.262e-24 | 2.668e-22 |
23 | REGULATION OF ESTABLISHMENT OF PLANAR POLARITY | 19 | 110 | 1.389e-24 | 2.81e-22 |
24 | POSITIVE REGULATION OF BIOSYNTHETIC PROCESS | 47 | 1805 | 1.095e-23 | 2.039e-21 |
25 | REGULATION OF PHOSPHORUS METABOLIC PROCESS | 45 | 1618 | 1.069e-23 | 2.039e-21 |
26 | TUBE DEVELOPMENT | 30 | 552 | 1.938e-23 | 3.468e-21 |
27 | REGULATION OF CELL DIFFERENTIATION | 43 | 1492 | 4.104e-23 | 7.073e-21 |
28 | BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY | 12 | 22 | 5.923e-23 | 9.842e-21 |
29 | EMBRYONIC MORPHOGENESIS | 29 | 539 | 1.611e-22 | 2.584e-20 |
30 | CARDIOVASCULAR SYSTEM DEVELOPMENT | 33 | 788 | 2.699e-22 | 4.05e-20 |
31 | CIRCULATORY SYSTEM DEVELOPMENT | 33 | 788 | 2.699e-22 | 4.05e-20 |
32 | POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 37 | 1135 | 2.115e-21 | 3.075e-19 |
33 | POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 37 | 1142 | 2.607e-21 | 3.675e-19 |
34 | POSITIVE REGULATION OF MOLECULAR FUNCTION | 44 | 1791 | 5.863e-21 | 8.023e-19 |
35 | REGULATION OF EMBRYONIC DEVELOPMENT | 17 | 114 | 6.397e-21 | 8.504e-19 |
36 | POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 35 | 1036 | 1.142e-20 | 1.398e-18 |
37 | POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 35 | 1036 | 1.142e-20 | 1.398e-18 |
38 | NEGATIVE REGULATION OF CELL COMMUNICATION | 37 | 1192 | 1.115e-20 | 1.398e-18 |
39 | EMBRYO DEVELOPMENT | 33 | 894 | 1.331e-20 | 1.588e-18 |
40 | POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 39 | 1395 | 2.807e-20 | 3.265e-18 |
41 | ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS | 33 | 957 | 1.064e-19 | 1.179e-17 |
42 | NEGATIVE REGULATION OF RESPONSE TO STIMULUS | 38 | 1360 | 1.051e-19 | 1.179e-17 |
43 | POSITIVE REGULATION OF CELL DIFFERENTIATION | 31 | 823 | 1.459e-19 | 1.579e-17 |
44 | PATTERN SPECIFICATION PROCESS | 24 | 418 | 2.784e-19 | 2.944e-17 |
45 | NEURON DIFFERENTIATION | 31 | 874 | 8.193e-19 | 8.472e-17 |
46 | EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING | 26 | 554 | 1.066e-18 | 1.079e-16 |
47 | CELL FATE COMMITMENT | 19 | 227 | 2.035e-18 | 2.015e-16 |
48 | NEUROGENESIS | 37 | 1402 | 2.53e-18 | 2.452e-16 |
49 | MORPHOGENESIS OF EMBRYONIC EPITHELIUM | 16 | 134 | 3.917e-18 | 3.72e-16 |
50 | CELL PROLIFERATION | 27 | 672 | 1.049e-17 | 9.766e-16 |
51 | SENSORY ORGAN DEVELOPMENT | 24 | 493 | 1.235e-17 | 1.127e-15 |
52 | POSITIVE REGULATION OF WNT SIGNALING PATHWAY | 16 | 152 | 3.077e-17 | 2.753e-15 |
53 | REGIONALIZATION | 20 | 311 | 4.251e-17 | 3.732e-15 |
54 | REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 21 | 365 | 6.11e-17 | 5.265e-15 |
55 | ANTERIOR POSTERIOR PATTERN SPECIFICATION | 17 | 194 | 6.744e-17 | 5.706e-15 |
56 | NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS | 28 | 801 | 8.468e-17 | 7.036e-15 |
57 | REGULATION OF CELL PROLIFERATION | 36 | 1496 | 1.618e-16 | 1.321e-14 |
58 | CELLULAR RESPONSE TO ORGANIC SUBSTANCE | 39 | 1848 | 4.524e-16 | 3.629e-14 |
59 | REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 37 | 1656 | 5.724e-16 | 4.514e-14 |
60 | HEART DEVELOPMENT | 22 | 466 | 6.412e-16 | 4.973e-14 |
61 | REGULATION OF CELL CYCLE | 29 | 949 | 7.274e-16 | 5.459e-14 |
62 | REGULATION OF CELL DEATH | 35 | 1472 | 7.172e-16 | 5.459e-14 |
63 | REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 38 | 1784 | 9.391e-16 | 6.936e-14 |
64 | STEM CELL DIFFERENTIATION | 16 | 190 | 1.116e-15 | 8.112e-14 |
65 | CELL DEVELOPMENT | 34 | 1426 | 1.984e-15 | 1.42e-13 |
66 | TUBE FORMATION | 14 | 129 | 2.163e-15 | 1.525e-13 |
67 | EPITHELIAL TO MESENCHYMAL TRANSITION | 11 | 56 | 2.724e-15 | 1.892e-13 |
68 | POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 29 | 1004 | 3.15e-15 | 2.156e-13 |
69 | NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS | 34 | 1517 | 1.229e-14 | 8.288e-13 |
70 | POSITIVE REGULATION OF CATALYTIC ACTIVITY | 34 | 1518 | 1.253e-14 | 8.329e-13 |
71 | NEURAL TUBE DEVELOPMENT | 14 | 149 | 1.664e-14 | 1.091e-12 |
72 | REGULATION OF CELLULAR PROTEIN LOCALIZATION | 22 | 552 | 2.093e-14 | 1.353e-12 |
73 | REGULATION OF CELLULAR RESPONSE TO STRESS | 24 | 691 | 2.337e-14 | 1.49e-12 |
74 | REGULATION OF RESPONSE TO STRESS | 33 | 1468 | 3.175e-14 | 1.997e-12 |
75 | NEURAL TUBE FORMATION | 12 | 94 | 3.283e-14 | 2.037e-12 |
76 | REGULATION OF KINASE ACTIVITY | 25 | 776 | 3.343e-14 | 2.047e-12 |
77 | REGULATION OF BINDING | 17 | 283 | 3.697e-14 | 2.234e-12 |
78 | REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 15 | 197 | 4.159e-14 | 2.419e-12 |
79 | REGULATION OF JNK CASCADE | 14 | 159 | 4.138e-14 | 2.419e-12 |
80 | SENSORY ORGAN MORPHOGENESIS | 16 | 239 | 4.151e-14 | 2.419e-12 |
81 | REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 18 | 337 | 4.626e-14 | 2.657e-12 |
82 | REGULATION OF TRANSFERASE ACTIVITY | 27 | 946 | 4.735e-14 | 2.687e-12 |
83 | NEGATIVE REGULATION OF GENE EXPRESSION | 33 | 1493 | 5.125e-14 | 2.873e-12 |
84 | CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 21 | 513 | 5.297e-14 | 2.899e-12 |
85 | REGULATION OF PROTEIN LOCALIZATION | 27 | 950 | 5.239e-14 | 2.899e-12 |
86 | MORPHOGENESIS OF A BRANCHING STRUCTURE | 14 | 167 | 8.206e-14 | 4.44e-12 |
87 | POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 29 | 1152 | 1.066e-13 | 5.666e-12 |
88 | VASCULATURE DEVELOPMENT | 20 | 469 | 1.072e-13 | 5.666e-12 |
89 | NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 27 | 983 | 1.185e-13 | 6.198e-12 |
90 | SOMITE DEVELOPMENT | 11 | 78 | 1.303e-13 | 6.736e-12 |
91 | REGULATION OF ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE | 7 | 14 | 1.82e-13 | 9.204e-12 |
92 | CONVERGENT EXTENSION | 7 | 14 | 1.82e-13 | 9.204e-12 |
93 | CELL ACTIVATION | 21 | 568 | 3.807e-13 | 1.905e-11 |
94 | SOMITOGENESIS | 10 | 62 | 4.342e-13 | 2.149e-11 |
95 | MESENCHYME DEVELOPMENT | 14 | 190 | 4.891e-13 | 2.395e-11 |
96 | POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 25 | 876 | 5.03e-13 | 2.438e-11 |
97 | SEGMENTATION | 11 | 89 | 5.854e-13 | 2.804e-11 |
98 | POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 12 | 119 | 5.905e-13 | 2.804e-11 |
99 | GASTRULATION | 13 | 155 | 6.665e-13 | 3.132e-11 |
100 | GLAND DEVELOPMENT | 18 | 395 | 6.912e-13 | 3.216e-11 |
101 | CELLULAR RESPONSE TO RETINOIC ACID | 10 | 65 | 7.142e-13 | 3.29e-11 |
102 | REGULATION OF MAPK CASCADE | 22 | 660 | 7.647e-13 | 3.488e-11 |
103 | EMBRYONIC ORGAN DEVELOPMENT | 18 | 406 | 1.098e-12 | 4.96e-11 |
104 | REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 19 | 470 | 1.225e-12 | 5.481e-11 |
105 | POSITIVE REGULATION OF CELL DEATH | 21 | 605 | 1.275e-12 | 5.652e-11 |
106 | INTRACELLULAR SIGNAL TRANSDUCTION | 32 | 1572 | 1.316e-12 | 5.776e-11 |
107 | REGULATION OF CELLULAR LOCALIZATION | 29 | 1277 | 1.408e-12 | 6.124e-11 |
108 | NEGATIVE REGULATION OF CELL DIFFERENTIATION | 21 | 609 | 1.446e-12 | 6.231e-11 |
109 | RESPONSE TO OXYGEN CONTAINING COMPOUND | 30 | 1381 | 1.605e-12 | 6.851e-11 |
110 | BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE | 12 | 131 | 1.882e-12 | 7.961e-11 |
111 | HEART MORPHOGENESIS | 14 | 212 | 2.19e-12 | 9.179e-11 |
112 | MESENCHYMAL CELL DIFFERENTIATION | 12 | 134 | 2.47e-12 | 1.026e-10 |
113 | POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 12 | 135 | 2.7e-12 | 1.112e-10 |
114 | NEGATIVE REGULATION OF CELL DEATH | 24 | 872 | 3.477e-12 | 1.419e-10 |
115 | DORSAL VENTRAL AXIS SPECIFICATION | 7 | 20 | 4.014e-12 | 1.624e-10 |
116 | CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND | 23 | 799 | 4.308e-12 | 1.728e-10 |
117 | EYE DEVELOPMENT | 16 | 326 | 4.878e-12 | 1.94e-10 |
118 | POSITIVE REGULATION OF CELL PROLIFERATION | 23 | 814 | 6.286e-12 | 2.479e-10 |
119 | EMBRYONIC ORGAN MORPHOGENESIS | 15 | 279 | 6.564e-12 | 2.567e-10 |
120 | REGULATION OF JUN KINASE ACTIVITY | 10 | 81 | 7.028e-12 | 2.725e-10 |
121 | NEGATIVE REGULATION OF MOLECULAR FUNCTION | 26 | 1079 | 7.27e-12 | 2.796e-10 |
122 | CELLULAR RESPONSE TO LIPID | 18 | 457 | 7.924e-12 | 3.022e-10 |
123 | POSITIVE REGULATION OF MAPK CASCADE | 18 | 470 | 1.261e-11 | 4.768e-10 |
124 | REPRODUCTIVE SYSTEM DEVELOPMENT | 17 | 408 | 1.331e-11 | 4.995e-10 |
125 | RESPONSE TO GROWTH FACTOR | 18 | 475 | 1.501e-11 | 5.588e-10 |
126 | REGULATION OF CELL MORPHOGENESIS | 19 | 552 | 2.008e-11 | 7.414e-10 |
127 | AXIS SPECIFICATION | 10 | 90 | 2.064e-11 | 7.564e-10 |
128 | REGULATION OF HYDROLASE ACTIVITY | 28 | 1327 | 2.178e-11 | 7.919e-10 |
129 | BETA CATENIN TCF COMPLEX ASSEMBLY | 8 | 43 | 3.128e-11 | 1.128e-09 |
130 | NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT | 7 | 26 | 3.325e-11 | 1.19e-09 |
131 | RESPONSE TO LIPID | 23 | 888 | 3.623e-11 | 1.287e-09 |
132 | APPENDAGE DEVELOPMENT | 12 | 169 | 3.873e-11 | 1.355e-09 |
133 | LIMB DEVELOPMENT | 12 | 169 | 3.873e-11 | 1.355e-09 |
134 | IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 15 | 323 | 5.236e-11 | 1.818e-09 |
135 | NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 21 | 740 | 5.61e-11 | 1.934e-09 |
136 | REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 13 | 220 | 5.708e-11 | 1.953e-09 |
137 | DOPAMINERGIC NEURON DIFFERENTIATION | 7 | 28 | 5.938e-11 | 2.017e-09 |
138 | POSITIVE REGULATION OF CELL CYCLE | 15 | 332 | 7.701e-11 | 2.585e-09 |
139 | REGULATION OF CELL DEVELOPMENT | 22 | 836 | 7.722e-11 | 2.585e-09 |
140 | DIGESTIVE TRACT MORPHOGENESIS | 8 | 48 | 7.978e-11 | 2.652e-09 |
141 | POSITIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 13 | 228 | 8.91e-11 | 2.94e-09 |
142 | MACROMOLECULAR COMPLEX DISASSEMBLY | 12 | 182 | 9.213e-11 | 3.019e-09 |
143 | REGULATION OF PROTEIN IMPORT | 12 | 183 | 9.82e-11 | 3.195e-09 |
144 | RESPONSE TO RETINOIC ACID | 10 | 107 | 1.184e-10 | 3.827e-09 |
145 | RESPONSE TO TRANSFORMING GROWTH FACTOR BETA | 11 | 144 | 1.202e-10 | 3.832e-09 |
146 | REGULATION OF CELLULAR COMPONENT MOVEMENT | 21 | 771 | 1.195e-10 | 3.832e-09 |
147 | MAMMARY GLAND EPITHELIUM DEVELOPMENT | 8 | 53 | 1.837e-10 | 5.814e-09 |
148 | REGULATION OF OSTEOBLAST DIFFERENTIATION | 10 | 112 | 1.87e-10 | 5.878e-09 |
149 | HEAD DEVELOPMENT | 20 | 709 | 1.921e-10 | 6e-09 |
150 | REGULATION OF STEM CELL DIFFERENTIATION | 10 | 113 | 2.043e-10 | 6.337e-09 |
151 | RHYTHMIC PROCESS | 14 | 298 | 2.083e-10 | 6.42e-09 |
152 | UROGENITAL SYSTEM DEVELOPMENT | 14 | 299 | 2.177e-10 | 6.664e-09 |
153 | KIDNEY MORPHOGENESIS | 9 | 82 | 2.442e-10 | 7.428e-09 |
154 | REGULATION OF TRANSPORT | 31 | 1804 | 2.48e-10 | 7.492e-09 |
155 | REGULATION OF MESENCHYMAL CELL PROLIFERATION | 7 | 34 | 2.634e-10 | 7.907e-09 |
156 | NEGATIVE REGULATION OF CELL PROLIFERATION | 19 | 643 | 2.687e-10 | 8.015e-09 |
157 | BLOOD VESSEL MORPHOGENESIS | 15 | 364 | 2.777e-10 | 8.232e-09 |
158 | REGULATION OF PROTEIN TARGETING | 14 | 307 | 3.077e-10 | 9.063e-09 |
159 | CELLULAR COMPONENT MORPHOGENESIS | 22 | 900 | 3.136e-10 | 9.176e-09 |
160 | POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 11 | 162 | 4.273e-10 | 1.242e-08 |
161 | REGULATION OF STEM CELL PROLIFERATION | 9 | 88 | 4.649e-10 | 1.343e-08 |
162 | REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 20 | 750 | 5.131e-10 | 1.474e-08 |
163 | REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 15 | 381 | 5.22e-10 | 1.49e-08 |
164 | MIDBRAIN DEVELOPMENT | 9 | 90 | 5.7e-10 | 1.617e-08 |
165 | EMBRYONIC DIGIT MORPHOGENESIS | 8 | 61 | 5.91e-10 | 1.667e-08 |
166 | DORSAL VENTRAL PATTERN FORMATION | 9 | 91 | 6.3e-10 | 1.766e-08 |
167 | REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 12 | 218 | 7.406e-10 | 2.064e-08 |
168 | CELL CELL SIGNALING | 20 | 767 | 7.57e-10 | 2.097e-08 |
169 | PROTEIN PHOSPHORYLATION | 22 | 944 | 7.681e-10 | 2.11e-08 |
170 | POSITIVE REGULATION OF JUN KINASE ACTIVITY | 8 | 63 | 7.71e-10 | 2.11e-08 |
171 | DEVELOPMENTAL GROWTH | 14 | 333 | 8.872e-10 | 2.414e-08 |
172 | CELLULAR RESPONSE TO ACID CHEMICAL | 11 | 175 | 9.733e-10 | 2.633e-08 |
173 | POSITIVE REGULATION OF TRANSFERASE ACTIVITY | 18 | 616 | 1.009e-09 | 2.714e-08 |
174 | POSITIVE REGULATION OF CELL DEVELOPMENT | 16 | 472 | 1.154e-09 | 3.086e-08 |
175 | REGULATION OF OSSIFICATION | 11 | 178 | 1.166e-09 | 3.1e-08 |
176 | REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 8 | 67 | 1.278e-09 | 3.359e-08 |
177 | EYE MORPHOGENESIS | 10 | 136 | 1.275e-09 | 3.359e-08 |
178 | REGULATION OF EPITHELIAL CELL PROLIFERATION | 13 | 285 | 1.386e-09 | 3.624e-08 |
179 | REGULATION OF CYTOPLASMIC TRANSPORT | 16 | 481 | 1.514e-09 | 3.936e-08 |
180 | POSITIVE REGULATION OF KINASE ACTIVITY | 16 | 482 | 1.56e-09 | 4.033e-08 |
181 | CAMERA TYPE EYE MORPHOGENESIS | 9 | 101 | 1.613e-09 | 4.146e-08 |
182 | POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 13 | 289 | 1.642e-09 | 4.198e-08 |
183 | REGULATION OF ORGANELLE ORGANIZATION | 24 | 1178 | 1.655e-09 | 4.207e-08 |
184 | REGULATION OF CELL CYCLE PROCESS | 17 | 558 | 1.666e-09 | 4.213e-08 |
185 | FC EPSILON RECEPTOR SIGNALING PATHWAY | 10 | 142 | 1.945e-09 | 4.893e-08 |
186 | REGULATION OF IMMUNE SYSTEM PROCESS | 26 | 1403 | 2.194e-09 | 5.489e-08 |
187 | CELL DEATH | 22 | 1001 | 2.28e-09 | 5.673e-08 |
188 | IMMUNE SYSTEM PROCESS | 31 | 1984 | 2.557e-09 | 6.328e-08 |
189 | PROTEIN COMPLEX SUBUNIT ORGANIZATION | 27 | 1527 | 2.743e-09 | 6.753e-08 |
190 | MUSCLE STRUCTURE DEVELOPMENT | 15 | 432 | 2.904e-09 | 7.113e-08 |
191 | LOCOMOTION | 23 | 1114 | 3.028e-09 | 7.376e-08 |
192 | IMMUNE SYSTEM DEVELOPMENT | 17 | 582 | 3.136e-09 | 7.599e-08 |
193 | DEVELOPMENTAL INDUCTION | 6 | 27 | 3.229e-09 | 7.704e-08 |
194 | REGULATION OF CATENIN IMPORT INTO NUCLEUS | 6 | 27 | 3.229e-09 | 7.704e-08 |
195 | AXIS ELONGATION | 6 | 27 | 3.229e-09 | 7.704e-08 |
196 | RESPONSE TO ABIOTIC STIMULUS | 22 | 1024 | 3.463e-09 | 8.22e-08 |
197 | CELLULAR COMPONENT DISASSEMBLY | 16 | 515 | 4.019e-09 | 9.492e-08 |
198 | POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 10 | 154 | 4.282e-09 | 1.006e-07 |
199 | RESPONSE TO ENDOGENOUS STIMULUS | 26 | 1450 | 4.377e-09 | 1.024e-07 |
200 | POSITIVE REGULATION OF STEM CELL DIFFERENTIATION | 7 | 50 | 4.588e-09 | 1.067e-07 |
201 | DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION | 17 | 602 | 5.191e-09 | 1.202e-07 |
202 | REGULATION OF MAP KINASE ACTIVITY | 13 | 319 | 5.4e-09 | 1.244e-07 |
203 | SKELETAL SYSTEM DEVELOPMENT | 15 | 455 | 5.847e-09 | 1.34e-07 |
204 | NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 9 | 117 | 5.981e-09 | 1.357e-07 |
205 | MAMMARY GLAND DEVELOPMENT | 9 | 117 | 5.981e-09 | 1.357e-07 |
206 | POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS | 12 | 263 | 6.204e-09 | 1.401e-07 |
207 | CELLULAR RESPONSE TO EXTERNAL STIMULUS | 12 | 264 | 6.474e-09 | 1.455e-07 |
208 | SINGLE ORGANISM CELL ADHESION | 15 | 459 | 6.576e-09 | 1.471e-07 |
209 | REGULATION OF CELL GROWTH | 14 | 391 | 6.957e-09 | 1.549e-07 |
210 | REGULATION OF PROTEIN CATABOLIC PROCESS | 14 | 393 | 7.422e-09 | 1.644e-07 |
211 | REGULATION OF INTRACELLULAR TRANSPORT | 17 | 621 | 8.231e-09 | 1.815e-07 |
212 | REGULATION OF MITOTIC CELL CYCLE | 15 | 468 | 8.531e-09 | 1.872e-07 |
213 | CELL CYCLE PROCESS | 22 | 1081 | 9.292e-09 | 2.03e-07 |
214 | REGULATION OF PROTEIN BINDING | 10 | 168 | 9.91e-09 | 2.155e-07 |
215 | OUTFLOW TRACT MORPHOGENESIS | 7 | 56 | 1.04e-08 | 2.251e-07 |
216 | KIDNEY EPITHELIUM DEVELOPMENT | 9 | 125 | 1.072e-08 | 2.31e-07 |
217 | REGULATION OF GROWTH | 17 | 633 | 1.092e-08 | 2.341e-07 |
218 | POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS | 14 | 406 | 1.12e-08 | 2.391e-07 |
219 | LYMPHOCYTE ACTIVATION | 13 | 342 | 1.239e-08 | 2.632e-07 |
220 | GROWTH | 14 | 410 | 1.267e-08 | 2.681e-07 |
221 | EMBRYONIC PATTERN SPECIFICATION | 7 | 58 | 1.338e-08 | 2.817e-07 |
222 | MESONEPHROS DEVELOPMENT | 8 | 90 | 1.385e-08 | 2.903e-07 |
223 | LEUKOCYTE ACTIVATION | 14 | 414 | 1.432e-08 | 2.959e-07 |
224 | POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 6 | 34 | 1.427e-08 | 2.959e-07 |
225 | CELLULAR RESPONSE TO ENDOGENOUS STIMULUS | 21 | 1008 | 1.437e-08 | 2.959e-07 |
226 | BRAIN MORPHOGENESIS | 6 | 34 | 1.427e-08 | 2.959e-07 |
227 | CELL CYCLE | 24 | 1316 | 1.444e-08 | 2.959e-07 |
228 | STEM CELL PROLIFERATION | 7 | 60 | 1.705e-08 | 3.479e-07 |
229 | POSITIVE REGULATION OF ORGANELLE ORGANIZATION | 16 | 573 | 1.807e-08 | 3.656e-07 |
230 | EPITHELIAL CELL DIFFERENTIATION | 15 | 495 | 1.801e-08 | 3.656e-07 |
231 | ANGIOGENESIS | 12 | 293 | 2.065e-08 | 4.16e-07 |
232 | RESPONSE TO DRUG | 14 | 431 | 2.372e-08 | 4.758e-07 |
233 | REGULATION OF MUSCLE ADAPTATION | 7 | 63 | 2.413e-08 | 4.819e-07 |
234 | REGULATION OF IMMUNE RESPONSE | 19 | 858 | 3.006e-08 | 5.977e-07 |
235 | REGULATION OF CELLULAR COMPONENT BIOGENESIS | 18 | 767 | 3.049e-08 | 6.037e-07 |
236 | LENS DEVELOPMENT IN CAMERA TYPE EYE | 7 | 66 | 3.356e-08 | 6.617e-07 |
237 | CENTRAL NERVOUS SYSTEM DEVELOPMENT | 19 | 872 | 3.884e-08 | 7.626e-07 |
238 | CONNECTIVE TISSUE DEVELOPMENT | 10 | 194 | 3.907e-08 | 7.638e-07 |
239 | DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS | 8 | 104 | 4.351e-08 | 8.471e-07 |
240 | RESPIRATORY SYSTEM DEVELOPMENT | 10 | 197 | 4.517e-08 | 8.756e-07 |
241 | PEPTIDYL SERINE MODIFICATION | 9 | 148 | 4.684e-08 | 9.006e-07 |
242 | DIGESTIVE SYSTEM DEVELOPMENT | 9 | 148 | 4.684e-08 | 9.006e-07 |
243 | COCHLEA MORPHOGENESIS | 5 | 21 | 4.873e-08 | 9.33e-07 |
244 | LEUKOCYTE CELL CELL ADHESION | 11 | 255 | 4.917e-08 | 9.377e-07 |
245 | RESPONSE TO ACID CHEMICAL | 12 | 319 | 5.261e-08 | 9.991e-07 |
246 | REGULATION OF CELL ADHESION | 16 | 629 | 6.565e-08 | 1.242e-06 |
247 | CELLULAR RESPONSE TO ABIOTIC STIMULUS | 11 | 263 | 6.734e-08 | 1.269e-06 |
248 | FC RECEPTOR SIGNALING PATHWAY | 10 | 206 | 6.88e-08 | 1.291e-06 |
249 | POSITIVE REGULATION OF HYDROLASE ACTIVITY | 19 | 905 | 6.971e-08 | 1.303e-06 |
250 | POSITIVE REGULATION OF MAP KINASE ACTIVITY | 10 | 207 | 7.2e-08 | 1.34e-06 |
251 | SEX DIFFERENTIATION | 11 | 266 | 7.556e-08 | 1.401e-06 |
252 | SKIN DEVELOPMENT | 10 | 211 | 8.617e-08 | 1.591e-06 |
253 | REGULATION OF CATABOLIC PROCESS | 17 | 731 | 8.844e-08 | 1.627e-06 |
254 | PHOSPHORYLATION | 22 | 1228 | 8.995e-08 | 1.648e-06 |
255 | REGULATION OF CELLULAR RESPONSE TO HEAT | 7 | 76 | 9.054e-08 | 1.652e-06 |
256 | PEPTIDYL THREONINE MODIFICATION | 6 | 46 | 9.479e-08 | 1.723e-06 |
257 | NEPHRON DEVELOPMENT | 8 | 115 | 9.561e-08 | 1.731e-06 |
258 | RENAL TUBULE DEVELOPMENT | 7 | 78 | 1.085e-07 | 1.958e-06 |
259 | BIOLOGICAL ADHESION | 20 | 1032 | 1.1e-07 | 1.977e-06 |
260 | ANTERIOR POSTERIOR AXIS SPECIFICATION | 6 | 48 | 1.232e-07 | 2.205e-06 |
261 | POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 8 | 121 | 1.42e-07 | 2.531e-06 |
262 | NEGATIVE REGULATION OF CELL GROWTH | 9 | 170 | 1.542e-07 | 2.739e-06 |
263 | PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS | 28 | 1977 | 1.578e-07 | 2.792e-06 |
264 | FOREBRAIN DEVELOPMENT | 12 | 357 | 1.783e-07 | 3.143e-06 |
265 | REGULATION OF CELL SUBSTRATE ADHESION | 9 | 173 | 1.79e-07 | 3.143e-06 |
266 | POSITIVE REGULATION OF OSSIFICATION | 7 | 84 | 1.817e-07 | 3.178e-06 |
267 | REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 10 | 229 | 1.849e-07 | 3.222e-06 |
268 | POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION | 5 | 27 | 1.889e-07 | 3.279e-06 |
269 | PALATE DEVELOPMENT | 7 | 85 | 1.972e-07 | 3.411e-06 |
270 | NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 16 | 684 | 2.052e-07 | 3.536e-06 |
271 | RESPONSE TO ALCOHOL | 12 | 362 | 2.071e-07 | 3.556e-06 |
272 | MESONEPHRIC TUBULE MORPHOGENESIS | 6 | 53 | 2.26e-07 | 3.866e-06 |
273 | GASTRULATION WITH MOUTH FORMING SECOND | 5 | 28 | 2.29e-07 | 3.904e-06 |
274 | NEGATIVE REGULATION OF GROWTH | 10 | 236 | 2.444e-07 | 4.15e-06 |
275 | NEGATIVE REGULATION OF BINDING | 8 | 131 | 2.622e-07 | 4.437e-06 |
276 | POSITIVE REGULATION OF GROWTH | 10 | 238 | 2.642e-07 | 4.454e-06 |
277 | EPITHELIAL CELL PROLIFERATION | 7 | 89 | 2.709e-07 | 4.551e-06 |
278 | INNER EAR MORPHOGENESIS | 7 | 92 | 3.404e-07 | 5.697e-06 |
279 | REGULATION OF PROTEOLYSIS | 16 | 711 | 3.45e-07 | 5.753e-06 |
280 | RESPONSE TO CYTOKINE | 16 | 714 | 3.649e-07 | 6.064e-06 |
281 | NEPHRON EPITHELIUM DEVELOPMENT | 7 | 93 | 3.666e-07 | 6.071e-06 |
282 | POSITIVE REGULATION OF CELL CYCLE PROCESS | 10 | 247 | 3.72e-07 | 6.13e-06 |
283 | CELLULAR RESPONSE TO STRESS | 24 | 1565 | 3.728e-07 | 6.13e-06 |
284 | NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 14 | 541 | 3.855e-07 | 6.295e-06 |
285 | NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 14 | 541 | 3.855e-07 | 6.295e-06 |
286 | RESPONSE TO EXTERNAL STIMULUS | 26 | 1821 | 4.295e-07 | 6.988e-06 |
287 | RESPONSE TO ORGANIC CYCLIC COMPOUND | 18 | 917 | 4.366e-07 | 7.078e-06 |
288 | PATTERNING OF BLOOD VESSELS | 5 | 32 | 4.621e-07 | 7.465e-06 |
289 | CELL MIGRATION INVOLVED IN GASTRULATION | 4 | 14 | 5.225e-07 | 8.412e-06 |
290 | POSITIVE REGULATION OF CATABOLIC PROCESS | 12 | 395 | 5.249e-07 | 8.423e-06 |
291 | POSITIVE REGULATION OF STEM CELL PROLIFERATION | 6 | 61 | 5.296e-07 | 8.468e-06 |
292 | CARDIAC CHAMBER DEVELOPMENT | 8 | 144 | 5.414e-07 | 8.585e-06 |
293 | EMBRYONIC AXIS SPECIFICATION | 5 | 33 | 5.425e-07 | 8.585e-06 |
294 | POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT | 5 | 33 | 5.425e-07 | 8.585e-06 |
295 | POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 10 | 258 | 5.547e-07 | 8.749e-06 |
296 | CELL MOTILITY | 17 | 835 | 5.77e-07 | 9.04e-06 |
297 | LOCALIZATION OF CELL | 17 | 835 | 5.77e-07 | 9.04e-06 |
298 | NEGATIVE REGULATION OF MITOTIC CELL CYCLE | 9 | 199 | 5.848e-07 | 9.131e-06 |
299 | REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 7 | 100 | 6.025e-07 | 9.376e-06 |
300 | RESPONSE TO INORGANIC SUBSTANCE | 13 | 479 | 6.113e-07 | 9.481e-06 |
301 | SKELETAL SYSTEM MORPHOGENESIS | 9 | 201 | 6.359e-07 | 9.831e-06 |
302 | REGULATION OF CARTILAGE DEVELOPMENT | 6 | 63 | 6.43e-07 | 9.906e-06 |
303 | SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION | 12 | 404 | 6.66e-07 | 1.021e-05 |
304 | MALE SEX DIFFERENTIATION | 8 | 148 | 6.67e-07 | 1.021e-05 |
305 | RESPONSE TO METAL ION | 11 | 333 | 7.131e-07 | 1.088e-05 |
306 | BONE REMODELING | 5 | 35 | 7.363e-07 | 1.12e-05 |
307 | MOVEMENT OF CELL OR SUBCELLULAR COMPONENT | 21 | 1275 | 7.468e-07 | 1.132e-05 |
308 | CARDIAC CHAMBER MORPHOGENESIS | 7 | 104 | 7.869e-07 | 1.189e-05 |
309 | PROTEASOMAL PROTEIN CATABOLIC PROCESS | 10 | 271 | 8.681e-07 | 1.307e-05 |
310 | REGULATION OF FAT CELL DIFFERENTIATION | 7 | 106 | 8.956e-07 | 1.34e-05 |
311 | FAT CELL DIFFERENTIATION | 7 | 106 | 8.956e-07 | 1.34e-05 |
312 | MITOTIC CELL CYCLE | 16 | 766 | 9.254e-07 | 1.38e-05 |
313 | PARAXIAL MESODERM DEVELOPMENT | 4 | 16 | 9.429e-07 | 1.397e-05 |
314 | APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS | 4 | 16 | 9.429e-07 | 1.397e-05 |
315 | POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS | 17 | 867 | 9.699e-07 | 1.433e-05 |
316 | REPRODUCTION | 21 | 1297 | 9.851e-07 | 1.451e-05 |
317 | POSITIVE REGULATION OF LOCOMOTION | 12 | 420 | 1.002e-06 | 1.471e-05 |
318 | REGULATION OF CELL JUNCTION ASSEMBLY | 6 | 68 | 1.016e-06 | 1.483e-05 |
319 | REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 7 | 108 | 1.017e-06 | 1.483e-05 |
320 | NEGATIVE REGULATION OF PHOSPHORYLATION | 12 | 422 | 1.053e-06 | 1.531e-05 |
321 | MESENCHYME MORPHOGENESIS | 5 | 38 | 1.125e-06 | 1.631e-05 |
322 | FORMATION OF PRIMARY GERM LAYER | 7 | 110 | 1.151e-06 | 1.663e-05 |
323 | NEURAL PRECURSOR CELL PROLIFERATION | 6 | 70 | 1.207e-06 | 1.739e-05 |
324 | REGULATION OF CHROMATIN BINDING | 4 | 17 | 1.228e-06 | 1.753e-05 |
325 | ESTABLISHMENT OF TISSUE POLARITY | 4 | 17 | 1.228e-06 | 1.753e-05 |
326 | REGULATION OF PRI MIRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 4 | 17 | 1.228e-06 | 1.753e-05 |
327 | POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT | 10 | 282 | 1.245e-06 | 1.771e-05 |
328 | COCHLEA DEVELOPMENT | 5 | 39 | 1.286e-06 | 1.824e-05 |
329 | EAR MORPHOGENESIS | 7 | 112 | 1.3e-06 | 1.838e-05 |
330 | POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 13 | 514 | 1.344e-06 | 1.895e-05 |
331 | NEGATIVE REGULATION OF CELL CYCLE | 12 | 433 | 1.378e-06 | 1.936e-05 |
332 | RESPONSE TO HORMONE | 17 | 893 | 1.453e-06 | 2.037e-05 |
333 | POSITIVE REGULATION OF CELL MATRIX ADHESION | 5 | 40 | 1.464e-06 | 2.045e-05 |
334 | POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION | 11 | 360 | 1.527e-06 | 2.128e-05 |
335 | REGULATION OF DEVELOPMENTAL GROWTH | 10 | 289 | 1.552e-06 | 2.138e-05 |
336 | CELL CELL ADHESION | 14 | 608 | 1.542e-06 | 2.138e-05 |
337 | EMBRYONIC HEART TUBE DEVELOPMENT | 6 | 73 | 1.549e-06 | 2.138e-05 |
338 | RESPONSE TO CALCIUM ION | 7 | 115 | 1.553e-06 | 2.138e-05 |
339 | POST ANAL TAIL MORPHOGENESIS | 4 | 18 | 1.573e-06 | 2.16e-05 |
340 | CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION | 8 | 166 | 1.588e-06 | 2.173e-05 |
341 | POSITIVE REGULATION OF PROTEOLYSIS | 11 | 363 | 1.656e-06 | 2.252e-05 |
342 | REGULATION OF APOPTOTIC SIGNALING PATHWAY | 11 | 363 | 1.656e-06 | 2.252e-05 |
343 | RESPONSE TO EXTRACELLULAR STIMULUS | 12 | 441 | 1.666e-06 | 2.261e-05 |
344 | LEUKOCYTE DIFFERENTIATION | 10 | 292 | 1.703e-06 | 2.304e-05 |
345 | REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY | 4 | 19 | 1.985e-06 | 2.678e-05 |
346 | POSITIVE REGULATION OF INTRACELLULAR TRANSPORT | 11 | 370 | 1.992e-06 | 2.679e-05 |
347 | REGULATION OF MUSCLE CELL APOPTOTIC PROCESS | 5 | 43 | 2.117e-06 | 2.83e-05 |
348 | MORPHOGENESIS OF AN EPITHELIAL SHEET | 5 | 43 | 2.117e-06 | 2.83e-05 |
349 | REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 6 | 77 | 2.123e-06 | 2.831e-05 |
350 | NEGATIVE REGULATION OF CELL DEVELOPMENT | 10 | 303 | 2.373e-06 | 3.144e-05 |
351 | BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS | 5 | 44 | 2.379e-06 | 3.144e-05 |
352 | POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION | 10 | 303 | 2.373e-06 | 3.144e-05 |
353 | NEGATIVE REGULATION OF PROTEIN BINDING | 6 | 79 | 2.47e-06 | 3.223e-05 |
354 | NEGATIVE REGULATION OF TRANSPORT | 12 | 458 | 2.465e-06 | 3.223e-05 |
355 | TRACHEA DEVELOPMENT | 4 | 20 | 2.473e-06 | 3.223e-05 |
356 | POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 4 | 20 | 2.473e-06 | 3.223e-05 |
357 | BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS | 4 | 20 | 2.473e-06 | 3.223e-05 |
358 | MUSCLE CELL DIFFERENTIATION | 9 | 237 | 2.493e-06 | 3.24e-05 |
359 | NEGATIVE REGULATION OF CATALYTIC ACTIVITY | 16 | 829 | 2.584e-06 | 3.349e-05 |
360 | THYMOCYTE AGGREGATION | 5 | 45 | 2.666e-06 | 3.436e-05 |
361 | T CELL DIFFERENTIATION IN THYMUS | 5 | 45 | 2.666e-06 | 3.436e-05 |
362 | OSTEOBLAST DIFFERENTIATION | 7 | 126 | 2.865e-06 | 3.673e-05 |
363 | REGULATION OF FIBROBLAST PROLIFERATION | 6 | 81 | 2.861e-06 | 3.673e-05 |
364 | CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND | 12 | 465 | 2.881e-06 | 3.683e-05 |
365 | REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 8 | 181 | 3.031e-06 | 3.858e-05 |
366 | APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT | 4 | 21 | 3.043e-06 | 3.858e-05 |
367 | POSITIVE REGULATION OF ADHERENS JUNCTION ORGANIZATION | 4 | 21 | 3.043e-06 | 3.858e-05 |
368 | REGULATION OF NEURON DIFFERENTIATION | 13 | 554 | 3.068e-06 | 3.879e-05 |
369 | REGULATION OF ACTIN FILAMENT BASED PROCESS | 10 | 312 | 3.08e-06 | 3.883e-05 |
370 | HEPATICOBILIARY SYSTEM DEVELOPMENT | 7 | 128 | 3.182e-06 | 3.991e-05 |
371 | REGULATION OF PHOSPHATASE ACTIVITY | 7 | 128 | 3.182e-06 | 3.991e-05 |
372 | WOUND HEALING | 12 | 470 | 3.215e-06 | 4.022e-05 |
373 | REGULATION OF CELL PROJECTION ORGANIZATION | 13 | 558 | 3.319e-06 | 4.14e-05 |
374 | REGULATION OF CYTOKINE PRODUCTION | 13 | 563 | 3.657e-06 | 4.538e-05 |
375 | RESPONSE TO WOUNDING | 13 | 563 | 3.657e-06 | 4.538e-05 |
376 | POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 5 | 48 | 3.693e-06 | 4.57e-05 |
377 | SOMATIC STEM CELL DIVISION | 4 | 22 | 3.705e-06 | 4.573e-05 |
378 | CARDIAC SEPTUM DEVELOPMENT | 6 | 85 | 3.795e-06 | 4.671e-05 |
379 | NEGATIVE REGULATION OF KINASE ACTIVITY | 9 | 250 | 3.857e-06 | 4.736e-05 |
380 | MAINTENANCE OF CELL NUMBER | 7 | 132 | 3.905e-06 | 4.782e-05 |
381 | CARDIAC SEPTUM MORPHOGENESIS | 5 | 49 | 4.097e-06 | 5.003e-05 |
382 | G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 19 | 1193 | 4.514e-06 | 5.499e-05 |
383 | REGULATION OF ADHERENS JUNCTION ORGANIZATION | 5 | 50 | 4.534e-06 | 5.508e-05 |
384 | PROTEIN AUTOPHOSPHORYLATION | 8 | 192 | 4.692e-06 | 5.685e-05 |
385 | NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS | 18 | 1087 | 4.906e-06 | 5.929e-05 |
386 | POSITIVE REGULATION OF FAT CELL DIFFERENTIATION | 5 | 51 | 5.008e-06 | 6.021e-05 |
387 | REGULATION OF GTPASE ACTIVITY | 14 | 673 | 5.003e-06 | 6.021e-05 |
388 | REGULATION OF CELL MATRIX ADHESION | 6 | 90 | 5.297e-06 | 6.353e-05 |
389 | POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY | 4 | 24 | 5.342e-06 | 6.373e-05 |
390 | REGULATION OF PROTEIN PHOSPHATASE TYPE 2A ACTIVITY | 4 | 24 | 5.342e-06 | 6.373e-05 |
391 | NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 9 | 262 | 5.644e-06 | 6.716e-05 |
392 | NEGATIVE REGULATION OF LOCOMOTION | 9 | 263 | 5.82e-06 | 6.908e-05 |
393 | ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY | 7 | 141 | 6.041e-06 | 7.153e-05 |
394 | REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE | 5 | 53 | 6.07e-06 | 7.169e-05 |
395 | REGULATION OF CYTOSKELETON ORGANIZATION | 12 | 502 | 6.29e-06 | 7.409e-05 |
396 | SYNAPSE ORGANIZATION | 7 | 145 | 7.263e-06 | 8.534e-05 |
397 | REGULATION OF KIDNEY DEVELOPMENT | 5 | 55 | 7.302e-06 | 8.558e-05 |
398 | DEVELOPMENTAL PROGRAMMED CELL DEATH | 4 | 26 | 7.459e-06 | 8.72e-05 |
399 | REGULATION OF CELL DIVISION | 9 | 272 | 7.634e-06 | 8.903e-05 |
400 | CARTILAGE DEVELOPMENT | 7 | 147 | 7.947e-06 | 9.244e-05 |
401 | REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 7 | 148 | 8.308e-06 | 9.616e-05 |
402 | POSITIVE REGULATION OF CELL GROWTH | 7 | 148 | 8.308e-06 | 9.616e-05 |
403 | NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 8 | 209 | 8.746e-06 | 0.0001005 |
404 | RESPONSE TO LITHIUM ION | 4 | 27 | 8.724e-06 | 0.0001005 |
405 | LYMPHOCYTE DIFFERENTIATION | 8 | 209 | 8.746e-06 | 0.0001005 |
406 | REGULATION OF CHROMOSOME ORGANIZATION | 9 | 278 | 9.096e-06 | 0.0001042 |
407 | NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 13 | 616 | 9.64e-06 | 0.0001102 |
408 | POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 11 | 437 | 9.714e-06 | 0.0001108 |
409 | VENTRICULAR SEPTUM MORPHOGENESIS | 4 | 28 | 1.014e-05 | 0.0001148 |
410 | MORPHOGENESIS OF A POLARIZED EPITHELIUM | 4 | 28 | 1.014e-05 | 0.0001148 |
411 | MAMMARY GLAND DUCT MORPHOGENESIS | 4 | 28 | 1.014e-05 | 0.0001148 |
412 | PALLIUM DEVELOPMENT | 7 | 153 | 1.033e-05 | 0.0001166 |
413 | VASCULOGENESIS | 5 | 59 | 1.035e-05 | 0.0001166 |
414 | AMEBOIDAL TYPE CELL MIGRATION | 7 | 154 | 1.078e-05 | 0.0001211 |
415 | DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS | 8 | 216 | 1.112e-05 | 0.0001247 |
416 | REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 5 | 60 | 1.124e-05 | 0.0001255 |
417 | POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION | 5 | 60 | 1.124e-05 | 0.0001255 |
418 | TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 14 | 724 | 1.145e-05 | 0.0001275 |
419 | REGULATION OF MUSCLE TISSUE DEVELOPMENT | 6 | 103 | 1.156e-05 | 0.0001277 |
420 | REGULATION OF MUSCLE ORGAN DEVELOPMENT | 6 | 103 | 1.156e-05 | 0.0001277 |
421 | STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 6 | 103 | 1.156e-05 | 0.0001277 |
422 | STEM CELL DIVISION | 4 | 29 | 1.172e-05 | 0.0001289 |
423 | CELLULAR RESPONSE TO INORGANIC SUBSTANCE | 7 | 156 | 1.172e-05 | 0.0001289 |
424 | POSITIVE REGULATION OF TRANSPORT | 16 | 936 | 1.198e-05 | 0.0001315 |
425 | POSITIVE REGULATION OF PROTEIN IMPORT | 6 | 104 | 1.222e-05 | 0.0001338 |
426 | REGULATION OF DEPHOSPHORYLATION | 7 | 158 | 1.274e-05 | 0.0001391 |
427 | CEREBRAL CORTEX DEVELOPMENT | 6 | 105 | 1.291e-05 | 0.0001406 |
428 | REGULATION OF PROTEIN STABILITY | 8 | 221 | 1.313e-05 | 0.0001427 |
429 | REGULATION OF SMOOTHENED SIGNALING PATHWAY | 5 | 62 | 1.322e-05 | 0.000143 |
430 | EMBRYONIC HEART TUBE MORPHOGENESIS | 5 | 62 | 1.322e-05 | 0.000143 |
431 | INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 6 | 106 | 1.363e-05 | 0.0001471 |
432 | POSITIVE REGULATION OF CYTOKINE PRODUCTION | 10 | 370 | 1.373e-05 | 0.0001479 |
433 | REGULATION OF EPIDERMIS DEVELOPMENT | 5 | 63 | 1.43e-05 | 0.0001537 |
434 | REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 4 | 31 | 1.541e-05 | 0.0001652 |
435 | POSITIVE REGULATION OF CELL ADHESION | 10 | 376 | 1.577e-05 | 0.0001687 |
436 | TELENCEPHALON DEVELOPMENT | 8 | 228 | 1.645e-05 | 0.0001755 |
437 | REGULATION OF ORGAN FORMATION | 4 | 32 | 1.754e-05 | 0.0001864 |
438 | EMBRYONIC FORELIMB MORPHOGENESIS | 4 | 32 | 1.754e-05 | 0.0001864 |
439 | SOMATIC STEM CELL POPULATION MAINTENANCE | 5 | 66 | 1.798e-05 | 0.0001901 |
440 | MESODERM MORPHOGENESIS | 5 | 66 | 1.798e-05 | 0.0001901 |
441 | POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY | 3 | 11 | 1.83e-05 | 0.000193 |
442 | REGULATION OF VASCULATURE DEVELOPMENT | 8 | 233 | 1.923e-05 | 0.0002024 |
443 | POSITIVE REGULATION OF IMMUNE RESPONSE | 12 | 563 | 1.978e-05 | 0.0002077 |
444 | CELLULAR RESPONSE TO ALCOHOL | 6 | 115 | 2.17e-05 | 0.0002274 |
445 | IN UTERO EMBRYONIC DEVELOPMENT | 9 | 311 | 2.217e-05 | 0.0002313 |
446 | RESPONSE TO OXYGEN LEVELS | 9 | 311 | 2.217e-05 | 0.0002313 |
447 | SYNAPSE ASSEMBLY | 5 | 69 | 2.235e-05 | 0.0002326 |
448 | SPECIFICATION OF SYMMETRY | 6 | 117 | 2.393e-05 | 0.0002485 |
449 | POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION | 3 | 12 | 2.431e-05 | 0.0002502 |
450 | TRACHEA MORPHOGENESIS | 3 | 12 | 2.431e-05 | 0.0002502 |
451 | MAMMARY GLAND EPITHELIAL CELL PROLIFERATION | 3 | 12 | 2.431e-05 | 0.0002502 |
452 | REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY | 3 | 12 | 2.431e-05 | 0.0002502 |
453 | POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION | 7 | 175 | 2.467e-05 | 0.0002533 |
454 | MESODERM DEVELOPMENT | 6 | 118 | 2.511e-05 | 0.0002574 |
455 | NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 5 | 71 | 2.569e-05 | 0.0002615 |
456 | SKIN EPIDERMIS DEVELOPMENT | 5 | 71 | 2.569e-05 | 0.0002615 |
457 | CELL FATE SPECIFICATION | 5 | 71 | 2.569e-05 | 0.0002615 |
458 | ENDOTHELIAL CELL DIFFERENTIATION | 5 | 72 | 2.75e-05 | 0.0002794 |
459 | REGULATION OF CELL CYCLE PHASE TRANSITION | 9 | 321 | 2.842e-05 | 0.0002881 |
460 | NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 6 | 121 | 2.894e-05 | 0.0002928 |
461 | REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 6 | 122 | 3.032e-05 | 0.000306 |
462 | HEMATOPOIETIC STEM CELL PROLIFERATION | 3 | 13 | 3.149e-05 | 0.0003157 |
463 | REGULATION OF SKELETAL MUSCLE ADAPTATION | 3 | 13 | 3.149e-05 | 0.0003157 |
464 | REGULATION OF CELL FATE SPECIFICATION | 3 | 13 | 3.149e-05 | 0.0003157 |
465 | REGULATION OF MUSCLE HYPERTROPHY | 4 | 37 | 3.162e-05 | 0.0003164 |
466 | REGULATION OF NEURON PROJECTION DEVELOPMENT | 10 | 408 | 3.169e-05 | 0.0003164 |
467 | T CELL DIFFERENTIATION | 6 | 123 | 3.175e-05 | 0.0003164 |
468 | RESPONSE TO STEROID HORMONE | 11 | 497 | 3.191e-05 | 0.0003173 |
469 | REGULATION OF MYELOID CELL DIFFERENTIATION | 7 | 183 | 3.285e-05 | 0.0003238 |
470 | PROTEIN COMPLEX BIOGENESIS | 17 | 1132 | 3.282e-05 | 0.0003238 |
471 | OSSIFICATION | 8 | 251 | 3.274e-05 | 0.0003238 |
472 | PROTEIN COMPLEX ASSEMBLY | 17 | 1132 | 3.282e-05 | 0.0003238 |
473 | NEURAL CREST CELL DIFFERENTIATION | 5 | 75 | 3.353e-05 | 0.0003298 |
474 | EPIDERMIS DEVELOPMENT | 8 | 253 | 3.464e-05 | 0.00034 |
475 | RESPONSE TO RADIATION | 10 | 413 | 3.513e-05 | 0.0003441 |
476 | EPITHELIAL CELL DEVELOPMENT | 7 | 186 | 3.644e-05 | 0.0003547 |
477 | RESPONSE TO UV | 6 | 126 | 3.637e-05 | 0.0003547 |
478 | NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 6 | 126 | 3.637e-05 | 0.0003547 |
479 | CELL CYCLE PHASE TRANSITION | 8 | 255 | 3.663e-05 | 0.0003558 |
480 | REGULATION OF BMP SIGNALING PATHWAY | 5 | 77 | 3.809e-05 | 0.0003692 |
481 | CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS | 7 | 188 | 3.901e-05 | 0.0003774 |
482 | POSITIVE REGULATION OF MEIOTIC CELL CYCLE | 3 | 14 | 3.993e-05 | 0.0003847 |
483 | REGULATION OF MONOCYTE DIFFERENTIATION | 3 | 14 | 3.993e-05 | 0.0003847 |
484 | POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 6 | 129 | 4.151e-05 | 0.0003982 |
485 | REGULATION OF REPRODUCTIVE PROCESS | 6 | 129 | 4.151e-05 | 0.0003982 |
486 | MAMMARY GLAND MORPHOGENESIS | 4 | 40 | 4.326e-05 | 0.0004117 |
487 | FORELIMB MORPHOGENESIS | 4 | 40 | 4.326e-05 | 0.0004117 |
488 | REGULATION OF MEIOTIC CELL CYCLE | 4 | 40 | 4.326e-05 | 0.0004117 |
489 | NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION | 4 | 40 | 4.326e-05 | 0.0004117 |
490 | SYNAPTIC SIGNALING | 10 | 424 | 4.384e-05 | 0.0004163 |
491 | PROTEIN STABILIZATION | 6 | 131 | 4.525e-05 | 0.0004288 |
492 | CELLULAR RESPONSE TO MECHANICAL STIMULUS | 5 | 80 | 4.581e-05 | 0.0004332 |
493 | ACTIVATION OF IMMUNE RESPONSE | 10 | 427 | 4.651e-05 | 0.000439 |
494 | EAR DEVELOPMENT | 7 | 195 | 4.921e-05 | 0.0004625 |
495 | REGULATION OF MUSCLE SYSTEM PROCESS | 7 | 195 | 4.921e-05 | 0.0004625 |
496 | NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS | 3 | 15 | 4.974e-05 | 0.0004666 |
497 | NEGATIVE REGULATION OF BMP SIGNALING PATHWAY | 4 | 42 | 5.259e-05 | 0.0004924 |
498 | NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION | 6 | 135 | 5.354e-05 | 0.0005003 |
499 | HAIR CYCLE | 5 | 83 | 5.469e-05 | 0.0005089 |
500 | MOLTING CYCLE | 5 | 83 | 5.469e-05 | 0.0005089 |
501 | NEGATIVE REGULATION OF TRANSFERASE ACTIVITY | 9 | 351 | 5.687e-05 | 0.0005281 |
502 | REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 4 | 43 | 5.777e-05 | 0.0005354 |
503 | NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH | 5 | 84 | 5.793e-05 | 0.0005359 |
504 | CELLULAR RESPONSE TO RADIATION | 6 | 137 | 5.812e-05 | 0.0005366 |
505 | PLACENTA DEVELOPMENT | 6 | 138 | 6.052e-05 | 0.0005577 |
506 | ORGAN INDUCTION | 3 | 16 | 6.1e-05 | 0.0005587 |
507 | REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS | 8 | 274 | 6.079e-05 | 0.0005587 |
508 | CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT | 3 | 16 | 6.1e-05 | 0.0005587 |
509 | MITOTIC CELL CYCLE CHECKPOINT | 6 | 139 | 6.301e-05 | 0.000576 |
510 | LABYRINTHINE LAYER DEVELOPMENT | 4 | 44 | 6.331e-05 | 0.0005776 |
511 | NEURON PROJECTION GUIDANCE | 7 | 205 | 6.747e-05 | 0.0006144 |
512 | TISSUE REMODELING | 5 | 87 | 6.853e-05 | 0.0006228 |
513 | NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 5 | 88 | 7.238e-05 | 0.0006565 |
514 | NEURON PROJECTION DEVELOPMENT | 11 | 545 | 7.325e-05 | 0.0006631 |
515 | CELLULAR RESPONSE TO LITHIUM ION | 3 | 17 | 7.38e-05 | 0.0006655 |
516 | NEGATIVE REGULATION OF STEM CELL PROLIFERATION | 3 | 17 | 7.38e-05 | 0.0006655 |
517 | RESPONSE TO NITROGEN COMPOUND | 14 | 859 | 7.451e-05 | 0.0006706 |
518 | REGULATION OF CHONDROCYTE DIFFERENTIATION | 4 | 46 | 7.553e-05 | 0.0006785 |
519 | NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION | 6 | 144 | 7.667e-05 | 0.0006873 |
520 | RESPONSE TO MECHANICAL STIMULUS | 7 | 210 | 7.85e-05 | 0.0007024 |
521 | ENDOTHELIUM DEVELOPMENT | 5 | 90 | 8.058e-05 | 0.0007196 |
522 | CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION | 9 | 368 | 8.169e-05 | 0.0007282 |
523 | RESPONSE TO ESTRADIOL | 6 | 146 | 8.275e-05 | 0.0007362 |
524 | REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 7 | 213 | 8.579e-05 | 0.0007618 |
525 | CELL DIVISION | 10 | 460 | 8.641e-05 | 0.0007659 |
526 | APOPTOTIC SIGNALING PATHWAY | 8 | 289 | 8.817e-05 | 0.0007762 |
527 | PERICARDIUM DEVELOPMENT | 3 | 18 | 8.825e-05 | 0.0007762 |
528 | INOSITOL PHOSPHATE MEDIATED SIGNALING | 3 | 18 | 8.825e-05 | 0.0007762 |
529 | UTERUS DEVELOPMENT | 3 | 18 | 8.825e-05 | 0.0007762 |
530 | TAXIS | 10 | 464 | 9.28e-05 | 0.0008148 |
531 | REGULATION OF DNA BINDING | 5 | 93 | 9.419e-05 | 0.0008253 |
532 | CELLULAR RESPONSE TO CALCIUM ION | 4 | 49 | 9.697e-05 | 0.0008481 |
533 | RESPONSE TO ESTROGEN | 7 | 218 | 9.916e-05 | 0.0008657 |
534 | REGULATION OF MUSCLE CELL DIFFERENTIATION | 6 | 152 | 0.0001033 | 0.0009005 |
535 | NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 5 | 95 | 0.0001042 | 0.0009045 |
536 | TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 5 | 95 | 0.0001042 | 0.0009045 |
537 | POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 4 | 50 | 0.000105 | 0.0009099 |
538 | GLAND MORPHOGENESIS | 5 | 97 | 0.000115 | 0.0009947 |
539 | REGULATION OF HORMONE LEVELS | 10 | 478 | 0.0001184 | 0.001022 |
540 | POSITIVE REGULATION OF DEVELOPMENTAL GROWTH | 6 | 156 | 0.0001192 | 0.001027 |
541 | POSITIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 5 | 98 | 0.0001207 | 0.001038 |
542 | POSITIVE REGULATION OF REPRODUCTIVE PROCESS | 4 | 52 | 0.0001225 | 0.00105 |
543 | TONGUE DEVELOPMENT | 3 | 20 | 0.0001224 | 0.00105 |
544 | POSITIVE REGULATION OF CELL SUBSTRATE ADHESION | 5 | 99 | 0.0001267 | 0.001083 |
545 | POSITIVE REGULATION OF FIBROBLAST PROLIFERATION | 4 | 53 | 0.000132 | 0.001127 |
546 | NEURON DEVELOPMENT | 12 | 687 | 0.0001337 | 0.00114 |
547 | VENTRICULAR SEPTUM DEVELOPMENT | 4 | 54 | 0.0001421 | 0.001208 |
548 | BONE RESORPTION | 3 | 21 | 0.0001423 | 0.001208 |
549 | REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY | 7 | 232 | 0.0001459 | 0.00123 |
550 | REGULATION OF LEUKOCYTE DIFFERENTIATION | 7 | 232 | 0.0001459 | 0.00123 |
551 | NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 5 | 102 | 0.0001458 | 0.00123 |
552 | POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 7 | 232 | 0.0001459 | 0.00123 |
553 | REGULATION OF NUCLEAR DIVISION | 6 | 163 | 0.0001516 | 0.001275 |
554 | REGULATION OF CIRCADIAN RHYTHM | 5 | 103 | 0.0001526 | 0.00128 |
555 | POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION | 5 | 103 | 0.0001526 | 0.00128 |
556 | CELL SUBSTRATE ADHESION | 6 | 164 | 0.0001567 | 0.001311 |
557 | REGULATION OF SECRETION | 12 | 699 | 0.0001571 | 0.001312 |
558 | NEURON PROJECTION MORPHOGENESIS | 9 | 402 | 0.0001592 | 0.001328 |
559 | MODULATION OF TRANSCRIPTION IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION | 3 | 22 | 0.0001642 | 0.001357 |
560 | POSITIVE REGULATION OF MUSCLE HYPERTROPHY | 3 | 22 | 0.0001642 | 0.001357 |
561 | POSITIVE REGULATION OF CARDIAC MUSCLE HYPERTROPHY | 3 | 22 | 0.0001642 | 0.001357 |
562 | REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS | 3 | 22 | 0.0001642 | 0.001357 |
563 | EMBRYONIC PLACENTA MORPHOGENESIS | 3 | 22 | 0.0001642 | 0.001357 |
564 | ODONTOGENESIS | 5 | 105 | 0.0001671 | 0.001378 |
565 | CARDIAC VENTRICLE DEVELOPMENT | 5 | 106 | 0.0001747 | 0.001439 |
566 | REGULATION OF AXONOGENESIS | 6 | 168 | 0.0001786 | 0.001469 |
567 | REGULATION OF OSTEOBLAST PROLIFERATION | 3 | 23 | 0.0001882 | 0.001544 |
568 | POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY | 6 | 171 | 0.0001967 | 0.001611 |
569 | NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS | 5 | 109 | 0.0001991 | 0.001625 |
570 | RESPONSE TO HYDROGEN PEROXIDE | 5 | 109 | 0.0001991 | 0.001625 |
571 | POSITIVE REGULATION OF INNATE IMMUNE RESPONSE | 7 | 246 | 0.0002091 | 0.001704 |
572 | POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 3 | 24 | 0.0002143 | 0.001734 |
573 | EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS | 3 | 24 | 0.0002143 | 0.001734 |
574 | CHONDROCYTE DIFFERENTIATION | 4 | 60 | 0.0002142 | 0.001734 |
575 | CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 3 | 24 | 0.0002143 | 0.001734 |
576 | CELL CYCLE G1 S PHASE TRANSITION | 5 | 111 | 0.0002167 | 0.001744 |
577 | COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION | 5 | 111 | 0.0002167 | 0.001744 |
578 | G1 S TRANSITION OF MITOTIC CELL CYCLE | 5 | 111 | 0.0002167 | 0.001744 |
579 | PEPTIDYL AMINO ACID MODIFICATION | 13 | 841 | 0.0002313 | 0.001859 |
580 | LENS FIBER CELL DIFFERENTIATION | 3 | 25 | 0.0002426 | 0.00194 |
581 | REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 3 | 25 | 0.0002426 | 0.00194 |
582 | REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 3 | 25 | 0.0002426 | 0.00194 |
583 | POSITIVE REGULATION OF NUCLEAR DIVISION | 4 | 62 | 0.0002432 | 0.001941 |
584 | HOMEOSTATIC PROCESS | 17 | 1337 | 0.0002501 | 0.001993 |
585 | NEUROEPITHELIAL CELL DIFFERENTIATION | 4 | 63 | 0.0002587 | 0.002058 |
586 | FEMALE SEX DIFFERENTIATION | 5 | 116 | 0.000266 | 0.002112 |
587 | REGULATION OF PEPTIDE TRANSPORT | 7 | 256 | 0.0002665 | 0.002112 |
588 | NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT | 3 | 26 | 0.0002733 | 0.002159 |
589 | REGULATION OF CELL FATE COMMITMENT | 3 | 26 | 0.0002733 | 0.002159 |
590 | RESPONSE TO KETONE | 6 | 182 | 0.0002753 | 0.002171 |
591 | NEGATIVE REGULATION OF CYTOPLASMIC TRANSPORT | 5 | 117 | 0.0002768 | 0.002179 |
592 | COVALENT CHROMATIN MODIFICATION | 8 | 345 | 0.0002955 | 0.002322 |
593 | CELL JUNCTION ORGANIZATION | 6 | 185 | 0.0003005 | 0.002358 |
594 | REGULATION OF HORMONE SECRETION | 7 | 262 | 0.0003066 | 0.002402 |
595 | CELLULAR RESPONSE TO UV | 4 | 66 | 0.0003095 | 0.00242 |
596 | CHROMATIN MODIFICATION | 10 | 539 | 0.0003113 | 0.002427 |
597 | REGULATION OF DENDRITE DEVELOPMENT | 5 | 120 | 0.0003112 | 0.002427 |
598 | POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION | 4 | 67 | 0.0003279 | 0.002547 |
599 | REGULATION OF SISTER CHROMATID SEGREGATION | 4 | 67 | 0.0003279 | 0.002547 |
600 | CHEMICAL HOMEOSTASIS | 13 | 874 | 0.0003352 | 0.002597 |
601 | EMBRYONIC SKELETAL SYSTEM DEVELOPMENT | 5 | 122 | 0.0003359 | 0.002597 |
602 | CELLULAR RESPONSE TO INTERFERON GAMMA | 5 | 122 | 0.0003359 | 0.002597 |
603 | MYELOID CELL DIFFERENTIATION | 6 | 189 | 0.0003369 | 0.0026 |
604 | PLACENTA BLOOD VESSEL DEVELOPMENT | 3 | 28 | 0.0003419 | 0.002625 |
605 | NEGATIVE REGULATION OF DENDRITE DEVELOPMENT | 3 | 28 | 0.0003419 | 0.002625 |
606 | METANEPHROS MORPHOGENESIS | 3 | 28 | 0.0003419 | 0.002625 |
607 | POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 4 | 68 | 0.0003471 | 0.002657 |
608 | TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 6 | 190 | 0.0003466 | 0.002657 |
609 | POSITIVE REGULATION OF MITOTIC CELL CYCLE | 5 | 123 | 0.0003488 | 0.002665 |
610 | NEGATIVE REGULATION OF NEURON DIFFERENTIATION | 6 | 191 | 0.0003564 | 0.002719 |
611 | POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS | 6 | 192 | 0.0003665 | 0.002791 |
612 | NEGATIVE REGULATION OF OSSIFICATION | 4 | 69 | 0.0003671 | 0.002791 |
613 | CELLULAR RESPONSE TO HORMONE STIMULUS | 10 | 552 | 0.0003758 | 0.002852 |
614 | REGULATION OF MEIOTIC NUCLEAR DIVISION | 3 | 29 | 0.00038 | 0.002875 |
615 | EMBRYONIC HINDLIMB MORPHOGENESIS | 3 | 29 | 0.00038 | 0.002875 |
616 | MUSCLE ORGAN MORPHOGENESIS | 4 | 70 | 0.0003879 | 0.002921 |
617 | INTERFERON GAMMA MEDIATED SIGNALING PATHWAY | 4 | 70 | 0.0003879 | 0.002921 |
618 | CELL CYCLE CHECKPOINT | 6 | 194 | 0.0003872 | 0.002921 |
619 | ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 6 | 195 | 0.000398 | 0.002992 |
620 | CHROMATIN ORGANIZATION | 11 | 663 | 0.0004006 | 0.003006 |
621 | POSITIVE REGULATION OF BINDING | 5 | 127 | 0.0004042 | 0.003028 |
622 | ENDODERM DEVELOPMENT | 4 | 71 | 0.0004095 | 0.003064 |
623 | PROTEIN LOCALIZATION | 20 | 1805 | 0.0004124 | 0.00308 |
624 | ESTABLISHMENT OR MAINTENANCE OF EPITHELIAL CELL APICAL BASAL POLARITY | 3 | 30 | 0.0004208 | 0.003103 |
625 | SMOOTH MUSCLE CELL DIFFERENTIATION | 3 | 30 | 0.0004208 | 0.003103 |
626 | POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 3 | 30 | 0.0004208 | 0.003103 |
627 | NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS | 3 | 30 | 0.0004208 | 0.003103 |
628 | MACROMOLECULAR COMPLEX ASSEMBLY | 17 | 1398 | 0.0004203 | 0.003103 |
629 | ESTABLISHMENT OF ENDOTHELIAL BARRIER | 3 | 30 | 0.0004208 | 0.003103 |
630 | RESPONSE TO X RAY | 3 | 30 | 0.0004208 | 0.003103 |
631 | MUSCLE CELL DEVELOPMENT | 5 | 128 | 0.000419 | 0.003103 |
632 | CELL PROJECTION ORGANIZATION | 13 | 902 | 0.0004525 | 0.003331 |
633 | POSITIVE REGULATION OF PROTEIN BINDING | 4 | 73 | 0.0004554 | 0.003342 |
634 | PANCREAS DEVELOPMENT | 4 | 73 | 0.0004554 | 0.003342 |
635 | RESPONSE TO LIGHT STIMULUS | 7 | 280 | 0.000457 | 0.003349 |
636 | REGULATION OF DENDRITE MORPHOGENESIS | 4 | 74 | 0.0004796 | 0.003509 |
637 | ACTIVATION OF INNATE IMMUNE RESPONSE | 6 | 204 | 0.0005054 | 0.003692 |
638 | ADIPOSE TISSUE DEVELOPMENT | 3 | 32 | 0.0005104 | 0.003722 |
639 | PROTEIN CATABOLIC PROCESS | 10 | 579 | 0.0005455 | 0.003968 |
640 | REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 6 | 207 | 0.0005458 | 0.003968 |
641 | NEGATIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 5 | 136 | 0.0005527 | 0.004012 |
642 | DIENCEPHALON DEVELOPMENT | 4 | 77 | 0.0005578 | 0.004042 |
643 | EMBRYONIC EYE MORPHOGENESIS | 3 | 33 | 0.0005594 | 0.004048 |
644 | REGULATION OF CELL CELL ADHESION | 8 | 380 | 0.0005608 | 0.004052 |
645 | HINDBRAIN DEVELOPMENT | 5 | 137 | 0.0005715 | 0.004123 |
646 | REGULATION OF PEPTIDE SECRETION | 6 | 209 | 0.0005741 | 0.004135 |
647 | REGULATION OF PROTEIN DEACETYLATION | 3 | 34 | 0.0006114 | 0.004377 |
648 | ORGAN FORMATION | 3 | 34 | 0.0006114 | 0.004377 |
649 | PROTEIN DESTABILIZATION | 3 | 34 | 0.0006114 | 0.004377 |
650 | NEURAL TUBE PATTERNING | 3 | 34 | 0.0006114 | 0.004377 |
651 | REGULATION OF SYNAPTIC PLASTICITY | 5 | 140 | 0.0006305 | 0.004507 |
652 | REGULATION OF PROTEIN SECRETION | 8 | 389 | 0.0006536 | 0.004665 |
653 | REGULATION OF GASTRULATION | 3 | 35 | 0.0006664 | 0.004734 |
654 | RESPONSE TO MINERALOCORTICOID | 3 | 35 | 0.0006664 | 0.004734 |
655 | EMBRYONIC CAMERA TYPE EYE DEVELOPMENT | 3 | 35 | 0.0006664 | 0.004734 |
656 | PLATELET ACTIVATION | 5 | 142 | 0.0006724 | 0.004769 |
657 | METANEPHROS DEVELOPMENT | 4 | 81 | 0.0006756 | 0.004777 |
658 | POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION | 4 | 81 | 0.0006756 | 0.004777 |
659 | NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT | 5 | 143 | 0.0006941 | 0.004901 |
660 | MODULATION OF SYNAPTIC TRANSMISSION | 7 | 301 | 0.0007014 | 0.004945 |
661 | JNK CASCADE | 4 | 82 | 0.0007076 | 0.004981 |
662 | CELLULAR RESPONSE TO STEROID HORMONE STIMULUS | 6 | 218 | 0.0007159 | 0.005027 |
663 | RESPONSE TO INTERFERON GAMMA | 5 | 144 | 0.0007163 | 0.005027 |
664 | POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 3 | 36 | 0.0007244 | 0.005068 |
665 | HEAD MORPHOGENESIS | 3 | 36 | 0.0007244 | 0.005068 |
666 | EMBRYONIC PLACENTA DEVELOPMENT | 4 | 83 | 0.0007406 | 0.005174 |
667 | NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION | 5 | 146 | 0.0007623 | 0.005318 |
668 | POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION | 4 | 84 | 0.0007747 | 0.00538 |
669 | POSITIVE REGULATION OF NEURON DIFFERENTIATION | 7 | 306 | 0.0007726 | 0.00538 |
670 | CELLULAR RESPONSE TO CYTOKINE STIMULUS | 10 | 606 | 0.0007747 | 0.00538 |
671 | HINDLIMB MORPHOGENESIS | 3 | 37 | 0.0007855 | 0.005419 |
672 | REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 5 | 147 | 0.0007861 | 0.005419 |
673 | NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 3 | 37 | 0.0007855 | 0.005419 |
674 | ESTABLISHMENT OR MAINTENANCE OF APICAL BASAL CELL POLARITY | 3 | 37 | 0.0007855 | 0.005419 |
675 | ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY | 3 | 37 | 0.0007855 | 0.005419 |
676 | CALCIUM ION TRANSPORT | 6 | 223 | 0.0008057 | 0.005545 |
677 | REGULATION OF CHROMOSOME SEGREGATION | 4 | 85 | 0.00081 | 0.005567 |
678 | CELLULAR RESPONSE TO NITROGEN COMPOUND | 9 | 505 | 0.0008361 | 0.005738 |
679 | SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 3 | 38 | 0.0008498 | 0.005815 |
680 | REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS | 3 | 38 | 0.0008498 | 0.005815 |
681 | REGULATION OF SYSTEM PROCESS | 9 | 507 | 0.0008597 | 0.005874 |
682 | REGULATION OF HEMOPOIESIS | 7 | 314 | 0.0008984 | 0.006129 |
683 | REGULATION OF CHROMATIN ORGANIZATION | 5 | 152 | 0.0009136 | 0.006224 |
684 | POSITIVE REGULATION OF VIRAL TRANSCRIPTION | 3 | 39 | 0.0009173 | 0.006231 |
685 | NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 3 | 39 | 0.0009173 | 0.006231 |
686 | SYSTEM PROCESS | 19 | 1785 | 0.0009591 | 0.006506 |
687 | CALCIUM MEDIATED SIGNALING | 4 | 90 | 0.001003 | 0.006795 |
688 | PROTEIN LOCALIZATION TO NUCLEUS | 5 | 156 | 0.001026 | 0.006941 |
689 | CELLULAR RESPONSE TO LIGHT STIMULUS | 4 | 91 | 0.001045 | 0.007061 |
690 | POSITIVE REGULATION OF MULTI ORGANISM PROCESS | 5 | 157 | 0.001056 | 0.007121 |
691 | POSITIVE REGULATION OF KIDNEY DEVELOPMENT | 3 | 41 | 0.001062 | 0.007123 |
692 | NEGATIVE REGULATION OF STRESS ACTIVATED MAPK CASCADE | 3 | 41 | 0.001062 | 0.007123 |
693 | NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 3 | 41 | 0.001062 | 0.007123 |
694 | PROSTATE GLAND DEVELOPMENT | 3 | 41 | 0.001062 | 0.007123 |
695 | CELL PART MORPHOGENESIS | 10 | 633 | 0.001078 | 0.007219 |
696 | DENDRITE MORPHOGENESIS | 3 | 42 | 0.00114 | 0.0076 |
697 | EPITHELIAL CELL MORPHOGENESIS | 3 | 42 | 0.00114 | 0.0076 |
698 | GENITALIA DEVELOPMENT | 3 | 42 | 0.00114 | 0.0076 |
699 | NEGATIVE REGULATION OF PROTEOLYSIS | 7 | 329 | 0.001177 | 0.007837 |
700 | REGENERATION | 5 | 161 | 0.001181 | 0.007851 |
701 | NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION | 3 | 43 | 0.001221 | 0.008095 |
702 | CEREBRAL CORTEX CELL MIGRATION | 3 | 43 | 0.001221 | 0.008095 |
703 | REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS | 4 | 95 | 0.001227 | 0.008121 |
704 | CELLULAR RESPONSE TO BIOTIC STIMULUS | 5 | 163 | 0.001248 | 0.008247 |
705 | PRIMITIVE STREAK FORMATION | 2 | 11 | 0.00127 | 0.008347 |
706 | ENDOCARDIUM DEVELOPMENT | 2 | 11 | 0.00127 | 0.008347 |
707 | NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 2 | 11 | 0.00127 | 0.008347 |
708 | OLFACTORY BULB INTERNEURON DEVELOPMENT | 2 | 11 | 0.00127 | 0.008347 |
709 | CHROMOSOME ORGANIZATION | 13 | 1009 | 0.001274 | 0.008359 |
710 | MYELOID LEUKOCYTE DIFFERENTIATION | 4 | 96 | 0.001275 | 0.008359 |
711 | BODY MORPHOGENESIS | 3 | 44 | 0.001306 | 0.008535 |
712 | NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 3 | 44 | 0.001306 | 0.008535 |
713 | REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 4 | 97 | 0.001325 | 0.00865 |
714 | MULTICELLULAR ORGANISM REPRODUCTION | 11 | 768 | 0.001338 | 0.008717 |
715 | REGULATION OF EPITHELIAL CELL MIGRATION | 5 | 166 | 0.001353 | 0.008803 |
716 | RESPONSE TO VITAMIN | 4 | 98 | 0.001377 | 0.008934 |
717 | REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 4 | 98 | 0.001377 | 0.008934 |
718 | ENDOTHELIAL CELL DEVELOPMENT | 3 | 45 | 0.001394 | 0.009024 |
719 | LUNG MORPHOGENESIS | 3 | 45 | 0.001394 | 0.009024 |
720 | RESPONSE TO CARBOHYDRATE | 5 | 168 | 0.001426 | 0.009218 |
721 | COGNITION | 6 | 251 | 0.00148 | 0.009549 |
722 | MODIFICATION OF MORPHOLOGY OR PHYSIOLOGY OF OTHER ORGANISM | 4 | 100 | 0.001483 | 0.009553 |
723 | NEGATIVE REGULATION OF DNA BINDING | 3 | 46 | 0.001486 | 0.009553 |
724 | HISTONE H3 ACETYLATION | 3 | 46 | 0.001486 | 0.009553 |
725 | KERATINOCYTE PROLIFERATION | 2 | 12 | 0.001519 | 0.00963 |
726 | ANTERIOR POSTERIOR AXIS SPECIFICATION EMBRYO | 2 | 12 | 0.001519 | 0.00963 |
727 | CARTILAGE MORPHOGENESIS | 2 | 12 | 0.001519 | 0.00963 |
728 | ANATOMICAL STRUCTURE REGRESSION | 2 | 12 | 0.001519 | 0.00963 |
729 | ROSTROCAUDAL NEURAL TUBE PATTERNING | 2 | 12 | 0.001519 | 0.00963 |
730 | HEART FORMATION | 2 | 12 | 0.001519 | 0.00963 |
731 | TRIPARTITE REGIONAL SUBDIVISION | 2 | 12 | 0.001519 | 0.00963 |
732 | POSITIVE REGULATION OF CATENIN IMPORT INTO NUCLEUS | 2 | 12 | 0.001519 | 0.00963 |
733 | EMBRYONIC CAMERA TYPE EYE FORMATION | 2 | 12 | 0.001519 | 0.00963 |
734 | LENS FIBER CELL DEVELOPMENT | 2 | 12 | 0.001519 | 0.00963 |
735 | REGULATION OF EXTENT OF CELL GROWTH | 4 | 101 | 0.001539 | 0.009741 |
736 | REGULATION OF CELL SIZE | 5 | 172 | 0.001582 | 0.009976 |
737 | POSITIVE REGULATION OF DEPHOSPHORYLATION | 3 | 47 | 0.001582 | 0.009976 |
738 | POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS | 3 | 47 | 0.001582 | 0.009976 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | FRIZZLED BINDING | 17 | 36 | 9.984e-31 | 9.275e-28 |
2 | WNT ACTIVATED RECEPTOR ACTIVITY | 14 | 22 | 5.404e-28 | 2.51e-25 |
3 | WNT PROTEIN BINDING | 15 | 31 | 2.07e-27 | 6.409e-25 |
4 | BETA CATENIN BINDING | 18 | 84 | 3.746e-25 | 8.699e-23 |
5 | G PROTEIN COUPLED RECEPTOR BINDING | 17 | 259 | 8.585e-15 | 1.595e-12 |
6 | ENZYME BINDING | 33 | 1737 | 3.466e-12 | 5.366e-10 |
7 | TRANSCRIPTION FACTOR BINDING | 19 | 524 | 8.174e-12 | 1.002e-09 |
8 | RECEPTOR BINDING | 30 | 1476 | 8.629e-12 | 1.002e-09 |
9 | SIGNAL TRANSDUCER ACTIVITY | 32 | 1731 | 1.706e-11 | 1.761e-09 |
10 | PROTEIN SERINE THREONINE KINASE ACTIVITY | 17 | 445 | 5.188e-11 | 4.819e-09 |
11 | RECEPTOR AGONIST ACTIVITY | 6 | 16 | 9.122e-11 | 7.704e-09 |
12 | MOLECULAR FUNCTION REGULATOR | 26 | 1353 | 1.018e-09 | 7.882e-08 |
13 | PROTEIN KINASE ACTIVITY | 18 | 640 | 1.847e-09 | 1.32e-07 |
14 | REGULATORY REGION NUCLEIC ACID BINDING | 20 | 818 | 2.291e-09 | 1.52e-07 |
15 | KINASE BINDING | 17 | 606 | 5.728e-09 | 3.548e-07 |
16 | RECEPTOR ACTIVATOR ACTIVITY | 6 | 32 | 9.691e-09 | 5.627e-07 |
17 | CORE PROMOTER PROXIMAL REGION DNA BINDING | 13 | 371 | 3.237e-08 | 1.769e-06 |
18 | RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING | 8 | 104 | 4.351e-08 | 2.246e-06 |
19 | PROTEIN DOMAIN SPECIFIC BINDING | 16 | 624 | 5.884e-08 | 2.877e-06 |
20 | SMAD BINDING | 7 | 72 | 6.199e-08 | 2.879e-06 |
21 | RECEPTOR REGULATOR ACTIVITY | 6 | 45 | 8.275e-08 | 3.661e-06 |
22 | KINASE ACTIVITY | 18 | 842 | 1.242e-07 | 5.244e-06 |
23 | TRANSCRIPTION FACTOR ACTIVITY PROTEIN BINDING | 15 | 588 | 1.705e-07 | 6.888e-06 |
24 | GAMMA CATENIN BINDING | 4 | 12 | 2.603e-07 | 1.008e-05 |
25 | PDZ DOMAIN BINDING | 7 | 90 | 2.926e-07 | 1.087e-05 |
26 | ARMADILLO REPEAT DOMAIN BINDING | 4 | 13 | 3.746e-07 | 1.339e-05 |
27 | RNA POLYMERASE II ACTIVATING TRANSCRIPTION FACTOR BINDING | 5 | 36 | 8.517e-07 | 2.931e-05 |
28 | TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 18 | 992 | 1.356e-06 | 4.499e-05 |
29 | RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING | 14 | 629 | 2.293e-06 | 7.344e-05 |
30 | PROTEIN DIMERIZATION ACTIVITY | 19 | 1149 | 2.612e-06 | 8.09e-05 |
31 | PROTEIN PHOSPHATASE TYPE 2A REGULATOR ACTIVITY | 4 | 21 | 3.043e-06 | 9.119e-05 |
32 | TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING | 10 | 315 | 3.353e-06 | 9.734e-05 |
33 | R SMAD BINDING | 4 | 23 | 4.468e-06 | 0.0001258 |
34 | TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING | 10 | 328 | 4.796e-06 | 0.000131 |
35 | UBIQUITIN LIKE PROTEIN LIGASE BINDING | 9 | 264 | 6.001e-06 | 0.0001593 |
36 | ACTIVATING TRANSCRIPTION FACTOR BINDING | 5 | 57 | 8.721e-06 | 0.000225 |
37 | CALMODULIN DEPENDENT PROTEIN KINASE ACTIVITY | 4 | 28 | 1.014e-05 | 0.0002546 |
38 | TRANSCRIPTION COACTIVATOR ACTIVITY | 9 | 296 | 1.5e-05 | 0.0003668 |
39 | TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING | 8 | 226 | 1.543e-05 | 0.0003676 |
40 | ENZYME REGULATOR ACTIVITY | 16 | 959 | 1.617e-05 | 0.0003756 |
41 | I SMAD BINDING | 3 | 11 | 1.83e-05 | 0.0004128 |
42 | NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY | 18 | 1199 | 1.866e-05 | 0.0004128 |
43 | DOUBLE STRANDED DNA BINDING | 14 | 764 | 2.086e-05 | 0.0004506 |
44 | CALMODULIN BINDING | 7 | 179 | 2.852e-05 | 0.0006021 |
45 | RHO GTPASE BINDING | 5 | 78 | 4.054e-05 | 0.0008187 |
46 | MAP KINASE ACTIVITY | 3 | 14 | 3.993e-05 | 0.0008187 |
47 | SEQUENCE SPECIFIC DNA BINDING | 16 | 1037 | 4.18e-05 | 0.0008263 |
48 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR BINDING | 3 | 15 | 4.974e-05 | 0.0009626 |
49 | CHROMATIN BINDING | 10 | 435 | 5.434e-05 | 0.00103 |
50 | PHOSPHATASE REGULATOR ACTIVITY | 5 | 87 | 6.853e-05 | 0.001273 |
51 | HORMONE RECEPTOR BINDING | 6 | 168 | 0.0001786 | 0.003254 |
52 | RECEPTOR SIGNALING PROTEIN ACTIVITY | 6 | 172 | 0.000203 | 0.003626 |
53 | PROTEIN HOMODIMERIZATION ACTIVITY | 12 | 722 | 0.0002118 | 0.003713 |
54 | BHLH TRANSCRIPTION FACTOR BINDING | 3 | 28 | 0.0003419 | 0.005775 |
55 | CADHERIN BINDING | 3 | 28 | 0.0003419 | 0.005775 |
56 | NF KAPPAB BINDING | 3 | 30 | 0.0004208 | 0.00698 |
57 | PHOSPHOLIPASE C ACTIVITY | 3 | 31 | 0.0004642 | 0.007565 |
58 | PROTEIN HETERODIMERIZATION ACTIVITY | 9 | 468 | 0.0004861 | 0.007787 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | WNT SIGNALOSOME | 10 | 11 | 5.45e-23 | 3.183e-20 |
2 | BETA CATENIN DESTRUCTION COMPLEX | 7 | 14 | 1.82e-13 | 5.314e-11 |
3 | ENDOCYTIC VESICLE MEMBRANE | 12 | 152 | 1.109e-11 | 2.16e-09 |
4 | ENDOCYTIC VESICLE | 12 | 256 | 4.583e-09 | 6.692e-07 |
5 | EXTRACELLULAR MATRIX | 14 | 426 | 2.05e-08 | 1.995e-06 |
6 | PROTEINACEOUS EXTRACELLULAR MATRIX | 13 | 356 | 1.992e-08 | 1.995e-06 |
7 | TRANSCRIPTION FACTOR COMPLEX | 12 | 298 | 2.49e-08 | 2.077e-06 |
8 | PROTEIN PHOSPHATASE TYPE 2A COMPLEX | 5 | 20 | 3.727e-08 | 2.721e-06 |
9 | PHOSPHATASE COMPLEX | 6 | 48 | 1.232e-07 | 7.995e-06 |
10 | SYNAPSE | 17 | 754 | 1.376e-07 | 8.036e-06 |
11 | LATERAL PLASMA MEMBRANE | 6 | 50 | 1.583e-07 | 8.404e-06 |
12 | CHROMOSOME | 18 | 880 | 2.388e-07 | 1.162e-05 |
13 | VESICLE MEMBRANE | 13 | 512 | 1.287e-06 | 5.783e-05 |
14 | TRANSCRIPTIONAL REPRESSOR COMPLEX | 6 | 74 | 1.679e-06 | 6.127e-05 |
15 | CHROMATIN | 12 | 441 | 1.666e-06 | 6.127e-05 |
16 | NUCLEAR CHROMATIN | 10 | 291 | 1.652e-06 | 6.127e-05 |
17 | CATALYTIC COMPLEX | 18 | 1038 | 2.577e-06 | 8.851e-05 |
18 | CELL SURFACE | 15 | 757 | 4.011e-06 | 0.0001301 |
19 | CYTOPLASMIC VESICLE PART | 13 | 601 | 7.407e-06 | 0.0002277 |
20 | INTRACELLULAR VESICLE | 19 | 1259 | 9.763e-06 | 0.0002851 |
21 | NUCLEAR TRANSCRIPTION FACTOR COMPLEX | 6 | 127 | 3.802e-05 | 0.001057 |
22 | SYNAPSE PART | 12 | 610 | 4.324e-05 | 0.001148 |
23 | CYTOSKELETAL PART | 19 | 1436 | 6.013e-05 | 0.001527 |
24 | PROTEIN KINASE COMPLEX | 5 | 90 | 8.058e-05 | 0.001961 |
25 | GOLGI LUMEN | 5 | 94 | 9.91e-05 | 0.002315 |
26 | MICROTUBULE CYTOSKELETON | 15 | 1068 | 0.0002104 | 0.004673 |
27 | CHROMOSOME CENTROMERIC REGION | 6 | 174 | 0.0002161 | 0.004673 |
28 | NUCLEAR CHROMOSOME | 10 | 523 | 0.000245 | 0.00511 |
29 | EXCITATORY SYNAPSE | 6 | 197 | 0.0004201 | 0.008461 |
30 | CYTOSKELETON | 21 | 1967 | 0.000474 | 0.00865 |
31 | NUCLEAR MEMBRANE | 7 | 280 | 0.000457 | 0.00865 |
32 | CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX | 3 | 31 | 0.0004642 | 0.00865 |
Num | Pathway | Pathview | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|---|
1 | hsa04310_Wnt_signaling_pathway | 98 | 151 | 8.08e-227 | 1.454e-224 | |
2 | hsa04916_Melanogenesis | 40 | 101 | 7.258e-69 | 6.532e-67 | |
3 | hsa04390_Hippo_signaling_pathway | 41 | 154 | 3.325e-62 | 1.995e-60 | |
4 | hsa04340_Hedgehog_signaling_pathway | 17 | 56 | 1.054e-26 | 4.743e-25 | |
5 | hsa04720_Long.term_potentiation | 15 | 70 | 4.266e-21 | 1.536e-19 | |
6 | hsa04114_Oocyte_meiosis | 15 | 114 | 1.038e-17 | 3.113e-16 | |
7 | hsa04520_Adherens_junction | 13 | 73 | 2.79e-17 | 7.173e-16 | |
8 | hsa04912_GnRH_signaling_pathway | 14 | 101 | 6.352e-17 | 1.429e-15 | |
9 | hsa04971_Gastric_acid_secretion | 11 | 74 | 7.114e-14 | 1.423e-12 | |
10 | hsa04662_B_cell_receptor_signaling_pathway | 11 | 75 | 8.304e-14 | 1.495e-12 | |
11 | hsa04010_MAPK_signaling_pathway | 16 | 268 | 2.451e-13 | 4.012e-12 | |
12 | hsa04012_ErbB_signaling_pathway | 11 | 87 | 4.525e-13 | 6.787e-12 | |
13 | hsa04370_VEGF_signaling_pathway | 10 | 76 | 3.644e-12 | 4.709e-11 | |
14 | hsa04020_Calcium_signaling_pathway | 13 | 177 | 3.662e-12 | 4.709e-11 | |
15 | hsa04510_Focal_adhesion | 13 | 200 | 1.725e-11 | 2.07e-10 | |
16 | hsa04722_Neurotrophin_signaling_pathway | 10 | 127 | 6.505e-10 | 7.318e-09 | |
17 | hsa04360_Axon_guidance | 10 | 130 | 8.188e-10 | 8.669e-09 | |
18 | hsa04650_Natural_killer_cell_mediated_cytotoxicity | 10 | 136 | 1.275e-09 | 1.275e-08 | |
19 | hsa04660_T_cell_receptor_signaling_pathway | 9 | 108 | 2.937e-09 | 2.782e-08 | |
20 | hsa04350_TGF.beta_signaling_pathway | 8 | 85 | 8.772e-09 | 7.895e-08 | |
21 | hsa04110_Cell_cycle | 9 | 128 | 1.321e-08 | 1.132e-07 | |
22 | hsa04062_Chemokine_signaling_pathway | 10 | 189 | 3.051e-08 | 2.496e-07 | |
23 | hsa04730_Long.term_depression | 7 | 70 | 5.085e-08 | 3.979e-07 | |
24 | hsa04270_Vascular_smooth_muscle_contraction | 8 | 116 | 1.023e-07 | 7.671e-07 | |
25 | hsa04330_Notch_signaling_pathway | 6 | 47 | 1.082e-07 | 7.793e-07 | |
26 | hsa04151_PI3K_AKT_signaling_pathway | 12 | 351 | 1.486e-07 | 1.029e-06 | |
27 | hsa04380_Osteoclast_differentiation | 8 | 128 | 2.194e-07 | 1.462e-06 | |
28 | hsa04970_Salivary_secretion | 7 | 89 | 2.709e-07 | 1.742e-06 | |
29 | hsa04540_Gap_junction | 7 | 90 | 2.926e-07 | 1.816e-06 | |
30 | hsa04664_Fc_epsilon_RI_signaling_pathway | 6 | 79 | 2.47e-06 | 1.482e-05 | |
31 | hsa04972_Pancreatic_secretion | 6 | 101 | 1.033e-05 | 5.995e-05 | |
32 | hsa04670_Leukocyte_transendothelial_migration | 6 | 117 | 2.393e-05 | 0.0001346 | |
33 | hsa04070_Phosphatidylinositol_signaling_system | 5 | 78 | 4.054e-05 | 0.0002211 | |
34 | hsa04530_Tight_junction | 6 | 133 | 4.926e-05 | 0.0002608 | |
35 | hsa03015_mRNA_surveillance_pathway | 5 | 83 | 5.469e-05 | 0.0002813 | |
36 | hsa04630_Jak.STAT_signaling_pathway | 6 | 155 | 0.0001151 | 0.0005753 | |
37 | hsa04620_Toll.like_receptor_signaling_pathway | 5 | 102 | 0.0001458 | 0.0007093 | |
38 | hsa04014_Ras_signaling_pathway | 7 | 236 | 0.0001621 | 0.0007678 | |
39 | hsa04910_Insulin_signaling_pathway | 5 | 138 | 0.0005907 | 0.002726 | |
40 | hsa04914_Progesterone.mediated_oocyte_maturation | 4 | 87 | 0.0008838 | 0.003977 | |
41 | hsa04210_Apoptosis | 4 | 89 | 0.0009623 | 0.004225 | |
42 | hsa04666_Fc_gamma_R.mediated_phagocytosis | 4 | 95 | 0.001227 | 0.005258 | |
43 | hsa00562_Inositol_phosphate_metabolism | 3 | 57 | 0.002756 | 0.01154 | |
44 | hsa04621_NOD.like_receptor_signaling_pathway | 3 | 59 | 0.00304 | 0.01244 | |
45 | hsa04810_Regulation_of_actin_cytoskeleton | 5 | 214 | 0.004064 | 0.01626 | |
46 | hsa04115_p53_signaling_pathway | 3 | 69 | 0.00473 | 0.01851 | |
47 | hsa04622_RIG.I.like_receptor_signaling_pathway | 3 | 71 | 0.005124 | 0.01962 | |
48 | hsa04710_Circadian_rhythm_._mammal | 2 | 23 | 0.005623 | 0.02109 | |
49 | hsa04740_Olfactory_transduction | 6 | 388 | 0.01211 | 0.04448 | |
50 | hsa04960_Aldosterone.regulated_sodium_reabsorption | 2 | 42 | 0.01802 | 0.06486 | |
51 | hsa04962_Vasopressin.regulated_water_reabsorption | 2 | 44 | 0.01967 | 0.06943 | |
52 | hsa04742_Taste_transduction | 2 | 52 | 0.02689 | 0.09307 | |
53 | hsa04920_Adipocytokine_signaling_pathway | 2 | 68 | 0.04393 | 0.1492 | |
54 | hsa04976_Bile_secretion | 2 | 71 | 0.04747 | 0.1582 | |
55 | hsa04120_Ubiquitin_mediated_proteolysis | 2 | 139 | 0.1486 | 0.4863 | |
56 | hsa04141_Protein_processing_in_endoplasmic_reticulum | 2 | 168 | 0.1991 | 0.6288 |
Num | lncRNA | miRNAs | miRNAs count | Gene | Sponge regulatory network | lncRNA log2FC | lncRNA pvalue | Gene log2FC | Gene pvalue | lncRNA-gene Pearson correlation |
---|---|---|---|---|---|---|---|---|---|---|
1 | MIR143HG |
hsa-miR-141-5p;hsa-miR-182-5p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-1976;hsa-miR-205-5p;hsa-miR-339-5p;hsa-miR-361-3p;hsa-miR-429;hsa-miR-590-3p | 10 | DAAM2 | Sponge network | -6.51 | 0 | -4.261 | 1.0E-5 | 0.654 |
2 | EMX2OS |
hsa-let-7a-3p;hsa-let-7f-2-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-205-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-3614-5p;hsa-miR-590-3p;hsa-miR-944 | 12 | AXIN2 | Sponge network | -6.205 | 0.00015 | -3.824 | 0.00033 | 0.595 |
3 | MAGI2-AS3 |
hsa-let-7f-1-3p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-18a-5p;hsa-miR-21-5p;hsa-miR-330-5p;hsa-miR-33a-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-429;hsa-miR-590-3p;hsa-miR-592;hsa-miR-629-3p | 14 | PRICKLE2 | Sponge network | -4.563 | 0 | -3.451 | 0 | 0.558 |
4 | RP11-166D19.1 |
hsa-let-7f-1-3p;hsa-miR-146a-5p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-18a-5p;hsa-miR-33a-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-429;hsa-miR-484;hsa-miR-590-3p;hsa-miR-592;hsa-miR-629-3p | 14 | PRICKLE2 | Sponge network | -4.209 | 2.0E-5 | -3.451 | 0 | 0.545 |
5 | MEG3 |
hsa-let-7b-3p;hsa-let-7f-1-3p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-18a-5p;hsa-miR-330-3p;hsa-miR-330-5p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-629-3p | 11 | PRICKLE2 | Sponge network | -3.613 | 0.00075 | -3.451 | 0 | 0.532 |
6 | MAGI2-AS3 |
hsa-let-7a-3p;hsa-let-7f-2-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-205-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-3614-5p;hsa-miR-590-3p | 11 | AXIN2 | Sponge network | -4.563 | 0 | -3.824 | 0.00033 | 0.525 |
7 | HAND2-AS1 |
hsa-let-7a-3p;hsa-let-7f-2-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-205-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-3614-5p;hsa-miR-590-3p;hsa-miR-944 | 12 | AXIN2 | Sponge network | -7.871 | 0 | -3.824 | 0.00033 | 0.523 |
8 | MEG3 |
hsa-let-7b-3p;hsa-let-7f-2-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-205-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-3614-5p;hsa-miR-944 | 11 | AXIN2 | Sponge network | -3.613 | 0.00075 | -3.824 | 0.00033 | 0.496 |
9 | RASSF8-AS1 |
hsa-let-7a-3p;hsa-let-7b-3p;hsa-miR-15a-5p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-193a-3p;hsa-miR-205-5p;hsa-miR-221-3p;hsa-miR-224-3p;hsa-miR-29b-3p;hsa-miR-29c-3p;hsa-miR-590-3p | 14 | LRP6 | Sponge network | -2.562 | 0.00163 | -1.511 | 0.00142 | 0.47 |
10 | MIR143HG |
hsa-let-7f-1-3p;hsa-miR-146a-5p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-18a-5p;hsa-miR-21-5p;hsa-miR-330-3p;hsa-miR-330-5p;hsa-miR-33a-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-429;hsa-miR-484;hsa-miR-590-3p;hsa-miR-629-3p | 16 | PRICKLE2 | Sponge network | -6.51 | 0 | -3.451 | 0 | 0.467 |
11 | RP11-166D19.1 |
hsa-let-7f-1-3p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-224-3p;hsa-miR-25-3p;hsa-miR-27a-3p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-452-5p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-629-3p | 15 | FZD4 | Sponge network | -4.209 | 2.0E-5 | -2.839 | 4.0E-5 | 0.456 |
12 | RASSF8-AS1 |
hsa-let-7a-3p;hsa-let-7b-3p;hsa-miR-15a-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-205-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-590-3p;hsa-miR-944 | 10 | AXIN2 | Sponge network | -2.562 | 0.00163 | -3.824 | 0.00033 | 0.431 |
13 | MIR143HG |
hsa-miR-130b-5p;hsa-miR-148b-5p;hsa-miR-15b-3p;hsa-miR-19b-1-5p;hsa-miR-25-3p;hsa-miR-30d-5p;hsa-miR-30e-5p;hsa-miR-32-5p;hsa-miR-361-3p;hsa-miR-363-3p;hsa-miR-429;hsa-miR-616-5p;hsa-miR-625-5p;hsa-miR-92a-3p;hsa-miR-92b-3p | 15 | CAMK2A | Sponge network | -6.51 | 0 | -4.611 | 0.0001 | 0.402 |
14 | RASSF8-AS1 |
hsa-let-7b-3p;hsa-miR-146a-5p;hsa-miR-150-5p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-21-5p;hsa-miR-33a-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-590-3p;hsa-miR-629-3p | 11 | PRICKLE2 | Sponge network | -2.562 | 0.00163 | -3.451 | 0 | 0.399 |
15 | DNM3OS |
hsa-let-7f-1-3p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-18a-5p;hsa-miR-330-3p;hsa-miR-33a-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-429;hsa-miR-484;hsa-miR-590-3p;hsa-miR-629-3p | 13 | PRICKLE2 | Sponge network | -3.933 | 0.00059 | -3.451 | 0 | 0.399 |
16 | RP11-389C8.2 |
hsa-let-7a-3p;hsa-miR-141-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-19b-3p;hsa-miR-200a-3p;hsa-miR-200c-3p;hsa-miR-3065-5p;hsa-miR-429;hsa-miR-93-5p | 14 | PRKACB | Sponge network | -3.089 | 2.0E-5 | -1.469 | 0.00691 | 0.394 |
17 | AC005682.5 | hsa-miR-106a-5p;hsa-miR-10a-3p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-182-5p;hsa-miR-191-5p;hsa-miR-200a-3p;hsa-miR-20b-5p;hsa-miR-28-5p;hsa-miR-3065-3p;hsa-miR-3065-5p | 11 | CCND2 | Sponge network | -2.193 | 0.07184 | -2.811 | 0.0014 | 0.394 |
18 | NR2F2-AS1 |
hsa-let-7a-3p;hsa-miR-15a-5p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-193a-3p;hsa-miR-205-5p;hsa-miR-221-3p;hsa-miR-224-3p;hsa-miR-590-3p | 11 | LRP6 | Sponge network | -3.785 | 0.00281 | -1.511 | 0.00142 | 0.392 |
19 | NR2F1-AS1 |
hsa-miR-15a-5p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-193a-3p;hsa-miR-221-3p;hsa-miR-224-3p;hsa-miR-29b-3p;hsa-miR-590-3p | 10 | LRP6 | Sponge network | -2.961 | 0.00154 | -1.511 | 0.00142 | 0.386 |
20 | ACTA2-AS1 |
hsa-let-7a-3p;hsa-miR-15a-5p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-193a-3p;hsa-miR-205-5p;hsa-miR-221-3p;hsa-miR-224-3p;hsa-miR-29b-3p;hsa-miR-590-3p | 12 | LRP6 | Sponge network | -6.142 | 0.00223 | -1.511 | 0.00142 | 0.384 |
21 | MAGI2-AS3 |
hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-19b-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-24-3p;hsa-miR-26b-3p;hsa-miR-30b-5p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-3607-3p;hsa-miR-590-3p | 12 | NFATC2 | Sponge network | -4.563 | 0 | -0.286 | 0.824 | 0.384 |
22 | RP11-244O19.1 | hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-191-5p;hsa-miR-200a-3p;hsa-miR-3065-3p;hsa-miR-3065-5p;hsa-miR-30d-3p;hsa-miR-93-5p | 12 | CCND2 | Sponge network | -1.318 | 0.0924 | -2.811 | 0.0014 | 0.383 |
23 | MAGI2-AS3 |
hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-224-3p;hsa-miR-25-3p;hsa-miR-27a-3p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-629-3p | 15 | FZD4 | Sponge network | -4.563 | 0 | -2.839 | 4.0E-5 | 0.382 |
24 | ACTA2-AS1 |
hsa-let-7a-3p;hsa-let-7f-2-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-205-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-3614-5p;hsa-miR-590-3p;hsa-miR-944 | 12 | AXIN2 | Sponge network | -6.142 | 0.00223 | -3.824 | 0.00033 | 0.379 |
25 | PWAR6 | hsa-miR-15a-5p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-193a-3p;hsa-miR-205-5p;hsa-miR-221-3p;hsa-miR-224-3p;hsa-miR-330-3p | 10 | LRP6 | Sponge network | -3.15 | 0.0082 | -1.511 | 0.00142 | 0.377 |
26 | DIO3OS | hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-191-5p;hsa-miR-200a-3p;hsa-miR-20b-5p;hsa-miR-324-3p;hsa-miR-378a-3p | 13 | CCND2 | Sponge network | -4.295 | 0.00689 | -2.811 | 0.0014 | 0.374 |
27 | RP11-284N8.3 |
hsa-miR-141-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-18a-5p;hsa-miR-19b-3p;hsa-miR-200a-3p;hsa-miR-3065-5p;hsa-miR-93-5p;hsa-miR-96-5p | 10 | PRKACB | Sponge network | -0.845 | 0.52848 | -1.469 | 0.00691 | 0.371 |
28 | MEG3 |
hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-25-3p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-576-5p;hsa-miR-629-3p | 13 | FZD4 | Sponge network | -3.613 | 0.00075 | -2.839 | 4.0E-5 | 0.369 |
29 | TPTEP1 |
hsa-let-7a-3p;hsa-let-7f-2-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-3614-5p;hsa-miR-590-3p | 10 | AXIN2 | Sponge network | -4.398 | 5.0E-5 | -3.824 | 0.00033 | 0.368 |
30 | ADAMTS9-AS1 |
hsa-let-7f-1-3p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-18a-5p;hsa-miR-21-5p;hsa-miR-330-5p;hsa-miR-429;hsa-miR-590-3p;hsa-miR-629-3p;hsa-miR-7-1-3p | 11 | PRICKLE2 | Sponge network | -8.573 | 0.00012 | -3.451 | 0 | 0.366 |
31 | HAND2-AS1 |
hsa-let-7f-1-3p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-18a-5p;hsa-miR-21-5p;hsa-miR-330-3p;hsa-miR-330-5p;hsa-miR-33a-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-429;hsa-miR-590-3p;hsa-miR-629-3p | 14 | PRICKLE2 | Sponge network | -7.871 | 0 | -3.451 | 0 | 0.365 |
32 | MAGI2-AS3 |
hsa-let-7a-3p;hsa-miR-141-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-3p;hsa-miR-200c-3p;hsa-miR-3065-5p;hsa-miR-429;hsa-miR-93-5p | 15 | PRKACB | Sponge network | -4.563 | 0 | -1.469 | 0.00691 | 0.359 |
33 | MIR143HG |
hsa-miR-141-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-2110;hsa-miR-30c-5p;hsa-miR-30d-3p;hsa-miR-30d-5p;hsa-miR-30e-5p;hsa-miR-330-5p;hsa-miR-616-5p;hsa-miR-92a-3p | 12 | WNT5A | Sponge network | -6.51 | 0 | -0.335 | 0.71496 | 0.356 |
34 | MIR143HG |
hsa-let-7f-1-3p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-224-3p;hsa-miR-25-3p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-629-3p | 13 | FZD4 | Sponge network | -6.51 | 0 | -2.839 | 4.0E-5 | 0.346 |
35 | ACTA2-AS1 |
hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-200c-3p;hsa-miR-224-3p;hsa-miR-25-3p;hsa-miR-27a-3p;hsa-miR-33a-3p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-708-5p | 13 | FZD4 | Sponge network | -6.142 | 0.00223 | -2.839 | 4.0E-5 | 0.343 |
36 | DNM3OS |
hsa-let-7f-1-3p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-25-3p;hsa-miR-27a-3p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-629-3p | 13 | FZD4 | Sponge network | -3.933 | 0.00059 | -2.839 | 4.0E-5 | 0.341 |
37 | RP11-13K12.1 | hsa-let-7a-3p;hsa-miR-15a-5p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-193a-3p;hsa-miR-205-5p;hsa-miR-221-3p;hsa-miR-29b-3p | 10 | LRP6 | Sponge network | -5.093 | 0.01151 | -1.511 | 0.00142 | 0.34 |
38 | RP11-166D19.1 |
hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-191-5p;hsa-miR-200a-3p;hsa-miR-20b-5p;hsa-miR-224-3p;hsa-miR-324-3p;hsa-miR-33a-3p;hsa-miR-378a-3p;hsa-miR-429;hsa-miR-550a-5p;hsa-miR-96-5p | 18 | CCND2 | Sponge network | -4.209 | 2.0E-5 | -2.811 | 0.0014 | 0.339 |
39 | ZNF667-AS1 | hsa-miR-15a-5p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-193a-3p;hsa-miR-205-5p;hsa-miR-221-3p;hsa-miR-224-3p;hsa-miR-29b-3p | 10 | LRP6 | Sponge network | -4.019 | 0.00137 | -1.511 | 0.00142 | 0.339 |
40 | RP11-439M11.1 | hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-191-5p;hsa-miR-20b-5p;hsa-miR-324-3p | 10 | CCND2 | Sponge network | -2.662 | 0.21003 | -2.811 | 0.0014 | 0.337 |
41 | DNM3OS |
hsa-miR-141-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-3p;hsa-miR-200c-3p;hsa-miR-3065-5p;hsa-miR-429;hsa-miR-93-5p;hsa-miR-96-5p | 15 | PRKACB | Sponge network | -3.933 | 0.00059 | -1.469 | 0.00691 | 0.336 |
42 | EMX2OS |
hsa-let-7f-1-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-18a-5p;hsa-miR-21-5p;hsa-miR-221-5p;hsa-miR-330-3p;hsa-miR-330-5p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-484;hsa-miR-590-3p;hsa-miR-629-3p | 13 | PRICKLE2 | Sponge network | -6.205 | 0.00015 | -3.451 | 0 | 0.335 |
43 | MAGI2-AS3 |
hsa-let-7a-3p;hsa-miR-15a-5p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-193a-3p;hsa-miR-205-5p;hsa-miR-221-3p;hsa-miR-224-3p;hsa-miR-590-3p | 11 | LRP6 | Sponge network | -4.563 | 0 | -1.511 | 0.00142 | 0.331 |
44 | HOXA11-AS | hsa-miR-141-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-3p;hsa-miR-200c-3p | 11 | PRKACB | Sponge network | -3.349 | 0.00194 | -1.469 | 0.00691 | 0.326 |
45 | AC003090.1 |
hsa-let-7f-1-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-18a-5p;hsa-miR-21-5p;hsa-miR-330-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-629-3p;hsa-miR-7-1-3p | 10 | PRICKLE2 | Sponge network | -7.817 | 0.00161 | -3.451 | 0 | 0.323 |
46 | MIR497HG |
hsa-let-7f-1-3p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-18a-5p;hsa-miR-21-5p;hsa-miR-221-5p;hsa-miR-330-5p;hsa-miR-33a-3p;hsa-miR-629-3p;hsa-miR-7-1-3p | 11 | PRICKLE2 | Sponge network | -6.146 | 0.00024 | -3.451 | 0 | 0.321 |
47 | MAGI2-AS3 |
hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-191-5p;hsa-miR-200a-3p;hsa-miR-20b-5p;hsa-miR-224-3p;hsa-miR-3065-5p;hsa-miR-30d-3p;hsa-miR-33a-3p;hsa-miR-378a-3p;hsa-miR-429;hsa-miR-9-3p;hsa-miR-93-5p | 19 | CCND2 | Sponge network | -4.563 | 0 | -2.811 | 0.0014 | 0.315 |
48 | RP11-284N8.3 |
hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-200a-3p;hsa-miR-3065-5p;hsa-miR-324-3p;hsa-miR-93-5p;hsa-miR-96-5p | 10 | CCND2 | Sponge network | -0.845 | 0.52848 | -2.811 | 0.0014 | 0.313 |
49 | MAGI2-AS3 |
hsa-miR-130a-5p;hsa-miR-141-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-24-3p;hsa-miR-30d-3p;hsa-miR-335-3p;hsa-miR-429;hsa-miR-589-3p;hsa-miR-9-3p | 10 | PRKCB | Sponge network | -4.563 | 0 | -1.378 | 0.12578 | 0.313 |
50 | EMX2OS |
hsa-let-7a-3p;hsa-miR-15a-5p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-193a-3p;hsa-miR-205-5p;hsa-miR-221-3p;hsa-miR-330-3p;hsa-miR-590-3p | 11 | LRP6 | Sponge network | -6.205 | 0.00015 | -1.511 | 0.00142 | 0.313 |
51 | RP11-389C8.2 |
hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-224-3p;hsa-miR-27a-3p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-629-3p | 12 | FZD4 | Sponge network | -3.089 | 2.0E-5 | -2.839 | 4.0E-5 | 0.311 |
52 | MAGI2-AS3 |
hsa-miR-141-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-2110;hsa-miR-30c-5p;hsa-miR-30d-3p;hsa-miR-30e-5p;hsa-miR-330-5p;hsa-miR-616-5p;hsa-miR-92a-3p | 11 | WNT5A | Sponge network | -4.563 | 0 | -0.335 | 0.71496 | 0.31 |
53 | NR2F2-AS1 |
hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-16-5p;hsa-miR-224-3p;hsa-miR-25-3p;hsa-miR-27a-3p;hsa-miR-27b-3p;hsa-miR-452-5p;hsa-miR-590-3p;hsa-miR-629-3p;hsa-miR-708-5p | 11 | FZD4 | Sponge network | -3.785 | 0.00281 | -2.839 | 4.0E-5 | 0.309 |
54 | MAGI2-AS3 |
hsa-miR-130b-5p;hsa-miR-148b-5p;hsa-miR-15b-3p;hsa-miR-19b-1-5p;hsa-miR-25-3p;hsa-miR-30e-5p;hsa-miR-32-5p;hsa-miR-363-3p;hsa-miR-429;hsa-miR-616-5p;hsa-miR-92a-3p;hsa-miR-92b-3p | 12 | CAMK2A | Sponge network | -4.563 | 0 | -4.611 | 0.0001 | 0.305 |
55 | LINC00865 |
hsa-miR-141-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-3p;hsa-miR-429 | 10 | PRKACB | Sponge network | -1.585 | 0.19508 | -1.469 | 0.00691 | 0.302 |
56 | GAS6-AS2 | hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-191-5p;hsa-miR-200a-3p;hsa-miR-20b-5p;hsa-miR-28-5p;hsa-miR-3065-5p;hsa-miR-324-3p;hsa-miR-429 | 14 | CCND2 | Sponge network | -1.941 | 0.0681 | -2.811 | 0.0014 | 0.301 |
57 | HAND2-AS1 |
hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-19b-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-2355-5p;hsa-miR-24-3p;hsa-miR-26b-3p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-3607-3p;hsa-miR-590-3p | 12 | NFATC2 | Sponge network | -7.871 | 0 | -0.286 | 0.824 | 0.297 |
58 | NR2F1-AS1 |
hsa-let-7f-1-3p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-18a-5p;hsa-miR-21-5p;hsa-miR-330-5p;hsa-miR-484;hsa-miR-590-3p;hsa-miR-629-3p | 10 | PRICKLE2 | Sponge network | -2.961 | 0.00154 | -3.451 | 0 | 0.295 |
59 | RP11-389C8.2 |
hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-191-5p;hsa-miR-200a-3p;hsa-miR-224-3p;hsa-miR-3065-3p;hsa-miR-3065-5p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-550a-5p;hsa-miR-93-5p | 17 | CCND2 | Sponge network | -3.089 | 2.0E-5 | -2.811 | 0.0014 | 0.293 |
60 | RP11-554A11.4 | hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-15b-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-191-5p;hsa-miR-20b-5p;hsa-miR-324-3p;hsa-miR-33a-3p | 10 | CCND2 | Sponge network | -5.361 | 2.0E-5 | -2.811 | 0.0014 | 0.29 |
61 | TPTEP1 |
hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-200c-3p;hsa-miR-224-3p;hsa-miR-27a-3p;hsa-miR-590-3p;hsa-miR-629-3p | 10 | FZD4 | Sponge network | -4.398 | 5.0E-5 | -2.839 | 4.0E-5 | 0.287 |
62 | MIR143HG |
hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-191-5p;hsa-miR-200a-3p;hsa-miR-20b-5p;hsa-miR-224-3p;hsa-miR-3065-3p;hsa-miR-3065-5p;hsa-miR-30d-3p;hsa-miR-324-3p;hsa-miR-33a-3p;hsa-miR-378a-3p;hsa-miR-429;hsa-miR-550a-5p;hsa-miR-93-5p | 21 | CCND2 | Sponge network | -6.51 | 0 | -2.811 | 0.0014 | 0.285 |
63 | WT1-AS |
hsa-let-7f-1-3p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-18a-5p;hsa-miR-330-5p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-590-3p;hsa-miR-629-3p | 10 | PRICKLE2 | Sponge network | -6.875 | 2.0E-5 | -3.451 | 0 | 0.282 |
64 | RP11-166D19.1 |
hsa-miR-141-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-3p;hsa-miR-200c-3p;hsa-miR-429;hsa-miR-96-5p | 13 | PRKACB | Sponge network | -4.209 | 2.0E-5 | -1.469 | 0.00691 | 0.282 |
65 | AC003090.1 |
hsa-miR-141-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200c-3p;hsa-miR-93-5p;hsa-miR-96-5p | 12 | PRKACB | Sponge network | -7.817 | 0.00161 | -1.469 | 0.00691 | 0.279 |
66 | FAM66C | hsa-let-7f-1-3p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-18a-5p;hsa-miR-21-5p;hsa-miR-330-5p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-429;hsa-miR-484;hsa-miR-590-3p;hsa-miR-629-3p;hsa-miR-7-1-3p | 14 | PRICKLE2 | Sponge network | -2.927 | 0.00012 | -3.451 | 0 | 0.279 |
67 | TRHDE-AS1 | hsa-let-7f-1-3p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-18a-5p;hsa-miR-21-5p;hsa-miR-330-3p;hsa-miR-330-5p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-484;hsa-miR-590-3p;hsa-miR-629-3p | 13 | PRICKLE2 | Sponge network | -6.205 | 0.01165 | -3.451 | 0 | 0.279 |
68 | HAND2-AS1 |
hsa-let-7a-3p;hsa-miR-15a-5p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-193a-3p;hsa-miR-205-5p;hsa-miR-221-3p;hsa-miR-330-3p;hsa-miR-590-3p | 11 | LRP6 | Sponge network | -7.871 | 0 | -1.511 | 0.00142 | 0.274 |
69 | MIR143HG |
hsa-miR-15a-5p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-193a-3p;hsa-miR-205-5p;hsa-miR-224-3p;hsa-miR-330-3p;hsa-miR-590-3p | 10 | LRP6 | Sponge network | -6.51 | 0 | -1.511 | 0.00142 | 0.273 |
70 | HAND2-AS1 |
hsa-let-7a-3p;hsa-miR-141-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-3p;hsa-miR-200c-3p;hsa-miR-429;hsa-miR-93-5p | 14 | PRKACB | Sponge network | -7.871 | 0 | -1.469 | 0.00691 | 0.272 |
71 | RP11-166D19.1 |
hsa-miR-130b-5p;hsa-miR-148b-5p;hsa-miR-15b-3p;hsa-miR-19b-1-5p;hsa-miR-25-3p;hsa-miR-32-5p;hsa-miR-363-3p;hsa-miR-429;hsa-miR-616-5p;hsa-miR-92a-3p | 10 | CAMK2A | Sponge network | -4.209 | 2.0E-5 | -4.611 | 0.0001 | 0.266 |
72 | SOCS2-AS1 | hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-200a-3p;hsa-miR-20b-5p;hsa-miR-324-3p;hsa-miR-33a-3p;hsa-miR-93-5p | 12 | CCND2 | Sponge network | -4.167 | 1.0E-5 | -2.811 | 0.0014 | 0.258 |
73 | MIR143HG |
hsa-miR-141-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-3p;hsa-miR-200c-3p;hsa-miR-3065-5p;hsa-miR-429;hsa-miR-93-5p | 14 | PRKACB | Sponge network | -6.51 | 0 | -1.469 | 0.00691 | 0.253 |
74 | ACTA2-AS1 |
hsa-let-7f-1-3p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-18a-5p;hsa-miR-33a-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-484;hsa-miR-590-3p | 10 | PRICKLE2 | Sponge network | -6.142 | 0.00223 | -3.451 | 0 | 0.253 |
75 | RP11-597D13.9 |
hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-200a-3p;hsa-miR-20b-5p;hsa-miR-30d-3p;hsa-miR-429;hsa-miR-93-5p;hsa-miR-96-5p | 14 | CCND2 | Sponge network | -2.494 | 0.07597 | -2.811 | 0.0014 | 0.252 |
76 | DNM3OS |
hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-191-5p;hsa-miR-200a-3p;hsa-miR-3065-3p;hsa-miR-3065-5p;hsa-miR-30d-3p;hsa-miR-33a-3p;hsa-miR-378a-3p;hsa-miR-429;hsa-miR-550a-5p;hsa-miR-93-5p;hsa-miR-96-5p | 19 | CCND2 | Sponge network | -3.933 | 0.00059 | -2.811 | 0.0014 | 0.25 |